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 Bacterial plant pathogens cause significant crop damage worldwide. They invade plant 
cells by producing a variety of virulence factors, including small molecule toxins and 
phytohormone mimics. Virulence of the model pathogen Pseudomonas syringae pv. tomato 
DC3000 (Pto) is regulated in part by the sigma factor HrpL. Our study of the HrpL regulon 
identified an uncharacterized, three-gene operon in Pto that is controlled by HrpL and related 
to the Erwinia hrp-associated systemic virulence (hsv) operon. Here, we demonstrate that the 
hsv operon contributes to the virulence of Pto on Arabidopsis thaliana and suppresses bacteria-
induced immune responses. We show that the Pto hsv-encoded enzymes synthesize a novel 
small molecule, phevamine A. This molecule consists of L-phenylalanine, L-valine and a 
modified spermidine, and is different from known small molecules produced by 
phytopathogens. We show that phevamine A suppresses a potentiation effect of spermidine 
and L-arginine on the reactive oxygen species burst generated upon recognition of bacterial 
flagellin. The hsv operon is found in the genomes of divergent bacterial genera, including 
~40% of P. syringae genomes, suggesting that phevamine A is a widely-distributed virulence 
factor in phytopathogens. Our work identifies a new small molecule virulence factor and 
reveals a new mechanism by which bacterial pathogens overcome plant defense. The workflow 




syringae to identify novel natural products from Pseudomonas syringae pv. syringae 
UMAF0158 and Pseudomonas syringae pv. actinidiae NZV-13. Another small molecule, 
pepticinnamin E, was identified from Actinobacteria bacterium OK006 for the first time and 
efforts are underway to understand its biosynthesis. This work highlights the power of -omics 
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CHAPTER 1: INTRODUCTION – ATP-GRASP ENZYMES IN NATURAL 
PRODUCT BIOSYNTHESIS 
 
1.1 OVERVIEW OF ATP-GRASP ENZYMES 
ATP-grasp enzymes share a highly conserved ATP-grasp fold that “grasps” a molecule 
of ATP. These enzymes are composed of an N-terminal N-domain, a central B-domain, a 
central A-domain, and a C-terminal C-domain (Fig. 1.1).1 The ATP-grasp site is located 
between the C-terminus and the central domains, where ATP is bound and used for substrate 
activation.1  
 
Figure 1.1. General structure of ATP-grasp enzymes. The X-ray crystal structure of E. coli 
glycinamide ribonucleotide synthetase (PDB 1GSO) is shown.2 ATP-grasp enzymes contain 
three subdomains: an N-terminal N-domain (blue), a central B-domain (red), a central A-
domain (purple) and a C-terminal C-domain (yellow). The ATP-grasp fold is located between 
the A- and C-domains. 
 
2 
The mechanism of ATP-grasp enzymes requires the carboxylic acid of one substrate to 
first be activated by one phosphate of ATP, thus forming a reactive acylphosphate intermediate 
and releasing ADP (Fig. 1.2).1, 3 Once activated, the carbonyl carbon is electrophilic and can 
undergo nucleophilic attack by an amine substrate, forming an amide bond and then releasing 
free phosphate (Pi) (Fig. 1.2).1, 3 This mechanism of amide bond formation is independent of 
the ribosome, and also differs from adenylation enzymes such as non-ribosomal peptide 
synthetases (NRPS).  
 
Figure 1.2. General mechanism of ATP-grasp-catalyzed amide bond formation. The 
carboxyl of one substrate is activated by phosphorylation, generating an acylphosphate 
intermediate. The amine of the second substrate then attacks the carbonyl of the acylphosphate, 
forming an amide bond and releasing free phosphate. 
 
Many in-depth studies of ATP-grasp enzymes have focused on those involved in amide 
formation in metabolic pathways, including fatty acid biosynthesis, purine biosynthesis, and 
gluconeogenesis.1, 4-8 The most well-studied ATP-grasp enzymes include D-Ala-D-Ala ligases 
in peptidoglycan biosynthesis, biotin carboxylases in fatty acid biosynthesis, and RimK in E. 
coli ribosome biogenesis.4-5, 7-8 Many ATP-grasp enzymes are also involved in the biosynthesis 
of secondary metabolites or natural products. Bioinformatic studies revealed that 
microorganisms harbor many ATP-grasp enzymes in their genomes, most of which are 
uncharacterized.3, 9 Most genome-mining efforts center on biosynthetic gene clusters 
 
3 
containing assembly line-like proteins, such as NRPS and polyketide synthases (PKS), and the 
clusters containing ATP-grasp enzymes have been mostly overlooked. 
This chapter focuses on microbial ATP-grasp enzymes that synthesize natural products, 
including their chemical mechanisms, substrate scope, and structures, to understand the 
molecular basis for substrate specificity. It will also discuss recent genome-mining efforts for 
ATP-grasp enzymes to discover new natural products.  
 
1.2 NATURAL PRODUCT PATHWAYS INVOLVING ATP-GRASP ENZYMES  
ATP-grasp enzymes contribute to the biosynthesis of many natural products. These 
compounds exhibit diverse structures (Fig. 1.3), biological activities, and mechanisms of 




Figure 1.3. Chemical structures of several ATP-grasp synthesized natural products. ATP-
grasp-catalyzed amide bonds are highlighted in red. 
 
Tabtoxin is a phytotoxin from Pseudomonas syringae that inhibits glutamine 
synthetase. The ATP-grasp enzyme TabS catalyzes the condensation of L-threonine to the 
tabtoxin precursor, tabtoxinine-β-lactam.10 TabS exhibits extremely broad substrate scope in 
vitro: it catalyzes formation of 136 other dipeptides using amino acids that have vastly different 
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chemical properties.10 These dipeptides include: all Met dipeptides, Cys-Leu, Ser-Phe, Trp-
Tyr, Glu-β-Ala, Pro-Thr, Asn-Gln, and Gly-Val.10 TabS can incorporate every proteinogenic 
amino acid into at least one dipeptide, which suggests that the active site of TabS is highly 
plastic to accommodate both aromatic amino acids, like Trp and Tyr, and charged amino acids 
as substrates.  
Another P. syringae phytotoxin is phaseolotoxin. This molecule contains a N-
sulfodiaminophosphinyl-L-ornithine attached to L-alanine and L-homoarginine, and inhibits 
plant ornithine carbamoyltransferase (OCT) and ornithine decarboxylase (ODC).11 The gene 
cluster encodes two ATP-grasp enzymes, PhtQ and PhtU, which have been proposed to 
catalyze Ala-hArg and Orn-Ala-hArg formation, respectively.11 However, these enzymes have 
not been biochemically characterized and their substrate scope is unknown. 
Phevamine A was identified by mining a P. syringae gene cluster encoding two ATP-
grasp enzymes.12 This cluster was upregulated by a sigma factor that controls a variety of 
virulence pathways in P. syringae.12-13 In vitro reconstitution of the enzymes encoded in the 
gene cluster, including the ATP-grasp enzymes HsvB and HsvC, enabled the identification and 
structural characterization of phevamine A, which consists of L-phenylalanine, L-valine, and 
amidinospermidine.12 Phevamine A was shown to promote bacterial virulence by suppressing 
plant immune response in Arabidopsis thaliana and Nicotiana benthamiana.12 In phevamine 
A biosynthesis, HsvC ligates L-Val to amidinospermidine and HsvB ligates L-Phe to L-Val-
amidinospermidine to form phevamine A.12 Under in vitro and heterologous expression 
conditions, HsvB also links a second L-Phe to phevamine A, forming phevamine B.12 In the 
absence of any cosubstrates, HsvB catalyzes formation of Phe-Phe dipeptide and Phe-Phe-Phe 
tripeptide.12 Additionally, HsvB can only activate L-Phe but not D-Phe or L-Phe-L-Phe 
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dipeptide as substrate (unpublished data). These data suggest that HsvB selectively activates 
the carboxyl of L-Phe to form the acylphosphate intermediate, but accepts both single amino 
acids and peptides as the nucleophile. The substrate scope of HsvC remains to be explored. 
The biosynthetic operon for mangotoxin shares similarity to that of phevamine A; it 
also consists of two ATP-grasp enzymes, MboC and MboD, and an amidinotransferase, 
MboE.14 Mangotoxin was identified in 2003 from some strains of P. syringae as a phytotoxin.15 
It acts as an antimetabolite that inhibits plant ornithine acetyltransferase (OAT) and causes 
necrosis in plant leaves.15 The structure of mangotoxin remains unknown and the functions of 
the biosynthetic enzymes including MboC and MboD are uncharacterized.  
Dapdiamides are tripeptide antibiotics produced by Pantoea agglomerans that inhibit 
the growth of the phytopathogenic bacterium Erwinia amylovora.16 Their biosynthesis requires 
two ATP-grasp enzymes, DdaF and DdaG.16 DdaG catalyzes amide bond formation between 
fumarate and 2,3-diaminopropionate (DAP), and DdaF catalyzes the second amide bond 
formation between Nβ-fumaramoyl-DAP and L-valine to form dapdiamide A, L-isoleucine to 
form dapdiamide B, or L-leucine to form dapdiamide C.16 DdaF will not accept Nβ-fumaroyl-
DAP as a substrate, and the fumaroyl moiety must first be converted to the fumaramoyl half 
amide.16 Further, DdaF will not accept Nα-fumaramoyl-DAP either, suggesting a narrow scope 
of DdaF for N-terminal substrate specificity.16 Similarly, DdaG prefers the native fumarate 
substrate over fumaramate, succinate, (R,R)-epoxysuccinate, (S,S)-epoxysuccinate, and cis-
epoxysuccinate on the N-terminus.16 DdaF is more flexible toward the C-terminal substrate 
and incorporates the branched aliphatic amino acids Val, Ile, and Leu.16 Further studies of 
DdaF with other amino acid substrates such as Ala or Thr would yield additional insights on 
the specificity of this enzyme. 
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Streptomyces lavendulae produces D-cycloserine, an aminoglycoside antibiotic that is 
active against tuberculosis.17 This molecule has an interesting scaffold, which is in part due to 
the ATP-grasp enzyme DscG, which cyclizes o-ureido-D-serine.17 This cyclization reaction is 
unique for an ATP-grasp enzyme, compared to the linear peptides this class of enzymes 
typically form. Interestingly, DcsG was able to catalyze formation of five- or six-membered 
ring products from the following linear substrates: D-homocysteine, β-aminooxy-D-alanine, D-
homoserine, D-2,4-diaminobutyrate, and D-ornithine.17 However, D-asparagine was not 
cyclized by DcsG.17 The chemical properties of the sidechains in homocysteine, homoserine, 
and ornithine are very different, but all three are cyclized by DcsG, suggesting the substrate 
specificity of the enzyme may be influenced by size of the sidechain rather than electrostatic 
interactions between the sidechain and the active site of the enzyme. 
The antioxidant shinorine from Microcystis aeruginosa is synthesized by MysC, which 
links glycine and 4-deoxygadusol, and MysD, which catalyzes the final step condensing the 
shinorine precursor to L-Ser (Fig. 1.4).3, 18 Although both of these enzymes are ATP-grasp 
enzymes, neither forms an amide bond. Instead of serine, MysD has been shown to also act on 
glycine and threonine, but other amino acid substrates have not been tested.18 Similarly, MysC 
substrate specificity has not been tested either. Since 4-deoxygadusol is a noncanonical 
substrate for ATP-grasp enzymes, MysC may have strict substrate control and perhaps a small 





Figure 1.4. Biosynthesis of shinorine by the ATP-grasp enzymes MysC and MysD. The 
ATP-grasp enzymes MysC and MysD synthesize shinorine from 4-deoxygadusol, but neither 
form an amide bond. The addition of Gly to 4-deoxygadusol by MysC is shown in red, and the 
addition of L-Ser to mycosporine glycine by MysD is shown in blue. 
 
Other natural products synthesized by ATP-grasp enzymes include: nikkomycins, 
friulimicin B, plumbemycins, argolaphos, and fosfazinomycin A.3-4, 19 Nikkomycins are 
peptidyl nucleoside antibiotics produced by Streptomyces tendae and biosynthesis of 
nikkomycins requires the ATP-grasp enzyme NikS.20 Insertional mutants in the nikkomycin 
pathway showed NikS is essential for production of nikkomycins I, J, X, and Z, however the 
substrate scope and structure of NikS remains to be explored.20 Friulimicin B is a lipopeptide 
antibiotic produced by Actinoplanes friuliensis and is synthesized in part by the ATP-grasp 
enzyme DabC.4, 21 However, DabC activity has not been reconstituted in vitro. Plumbemycins 
are tripeptide antibiotics produced by Streptomyces plumbeus.22 The plumbemycin gene 
cluster has been elucidated and contains several ATP-grasp enzymes, but these enzymes have 
not been characterized.23 Argolaphos A and B are synthesized in part by an ATP-grasp enzyme 
that has not been biosynthetically characterized.19 These compounds are broad-spectrum 
antibacterial phosphonopeptides produced by Streptomyces monomycini.19 Finally, the 
fosfazinomycin A pathway encodes the putative ATP-grasp enzyme FzmF, which has not been 
 
9 
biochemically characterized.24 Fosfazinomycin A is produced by Streptomyces sp. WM6372 
and is active against some filamentous fungi.24-26  
ATP-grasp enzymes as a whole have robust substrate scope and contribute to the 
biosynthesis of many natural products. These enzymes are present in a diverse assortment of 
microbes and produce many varied natural product scaffolds. 
 
1.3 STRUCTURES AND MECHANISMS OF ATP-GRASP ENZYMES IN NATURAL 
PRODUCT BIOSYNTHESIS  
ATP-grasp enzymes are composed of four subdomains: N, A, B, and C. Between the 
ATP-grasp subdomains are several long loop regions, which allow for protein flexibility and 
recognition of structurally diverse substrates.27 Crystal structures of ATP-grasp enzymes 
provide a structural basis for understanding ATP-grasp activity and substrate scope. 
X-ray crystallography is a widely-used method for identification of crucial protein 
active site residues and characterization of macromolecular structure. Several ATP-grasp 
enzymes involved in secondary metabolite production have been crystallized, including MdnB 
and MdnC in the microviridin J pathway, PGM1 in the pheganomycin pathway, BacD in the 
bacilysin pathway, RizA in the rhizocticin pathway, and BL00235, which catalyzes dipeptide 
formation.  
Microviridin J is a large macrocyclic ribosomally synthesized and post-translationally 
modified peptide (RiPP), composed of 13 modified amino acids.27 The ATP-grasp enzyme 
MdnC catalyzes two lactonizations, forming the first two macrocycles of microviridn J, and 
MdnB catalyzes the final macrocycle formation (Fig. 1.5A).27 Both MdnB and MdnC form 
homodimer assemblies with interface areas of 2,422 and 2,748 Å2, respectively.27 One 
conserved ATP-grasp α-helix, α3, extends along the central domain of the enzyme. In the 
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microviridin enzymes, this α-helix is 23 residues long, which is much longer than typical α3 
helices.27 However, most ATP-grasp enzymes involved in natural product biosynthesis act on 
substrates much smaller than RiPPs. This natural product presents an interesting case where 
MdnB and MdnC also possess a RiPP recognition element for recognition of the leader peptide 
on the peptide substrate. 
 
Figure 1.5. Chemical structures of large ATP-grasp synthesized secondary metabolites. 
(A) Structure of microviridin J. (B) Structure of pheganomycin showing the two 
nonproteinogenic amino acid components: a, (S)-2-(3,5-dihydroxy-4-hydroxymethyl)phenyl-
2-guanidinoacetic acid, and b, (S)-2-amino-3,3-dimethylbutanoic acid (L-tert-leucine). ATP-
grasp-catalyzed lactonizations are shown in blue and ATP-grasp-catalyzed amide bonds are 
shown in red. 
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PGM1 is responsible for peptide linkages to generate the linear peptide pheganomycin 
and related analogs (Fig. 1.5B).28 Pheganomycin is an anti-Mycobacterium antibiotic produced 
by the yeast species Saccharomyces cerevisiae. The molecule is composed of two 
nonproteinogenic amino acids, (S)-2-(3,5-dihydroxy-4-hydroxymethyl)phenyl-2-
guanidinoacetic acid (a) and (S)-2-amino-3,3-dimethylbutanoic acid (b), and two 
proteinogenic L-amino acids, asparagine and lysine.28 PGM1 links the nonproteinogenic amino 
acid (a) to a core peptide.28 The crystal structure obtained for PGM1 revealed a large cavity 
with a deep cleft in the center of PGM1 with the ATP-binding site located deep in this cavity 
(Fig. 1.6).28 PGM1 therefore has a large active site to accommodate larger peptide substrates 
and may be very promiscuous, accepting many peptide substrates. PGM1 was found to to 
accept other nonproteinogenic amino acids with guanidino groups as the N-terminal substrate, 
including (S)-2-guanidino-2-phenylacetic acid, (R)-2-guanidino-2-phenylacetic acid, 2-
guanidinoacetic acid, and creatine.28 Conversely, (S)-2-amino-2-(3,5-dihydroxyphenyl)acetic 
acid, 3-guanidinopropanoic acid, 4-guanidinobutanoic acid, and all L-amino acids were unable 
to be linked at the N-terminus to the rest of the pheganomycin peptide by PGM1.28 All L-amino 
acids were also unable to serve as C-terminal substrates.28 The natural C-terminal substrates 
are the peptides NVKDR, NVKDGPT, NV, NVKDG, and NVKDGP.28 Other accepted C-
terminal substrates include AVKDR, NAKDR, NVADR, AAKDR, AAADR, aspartame, 
MRFA, GNNRPVYIPQPRPPHRPL, and RVRRPVYIPQPRPPHPRL.28 This presents an 
interesting case, where single amino acids are not accepted substrates by the ATP-grasp 




Figure 1.6. Crystal structure of PGM1 (PDB 3WVQ). The large cleft containing the ATP-
grasp binding cavity is labeled. 
 
Other ATP-grasp enzymes accept single amino acids, including BacD, BL00235, and 
RizA. The enzymes BacD and BL00235 are structurally similar, but only share ~20% sequence 
identity (Fig. 1.7A).29-30 The enzyme BacD, previously named YwfE, links L-Ala and 
anticapsin to form bacilysin, an antibiotic and antifungal dipeptide produced by Bacillus 
subtilis.31-33 Surprisingly, L-Gln is capable of being linked to L-Ala by BacD because anticapsin 
can act as an analog of L-Gln in vivo.34 However, L-Ala must be the N-terminal residue, thus 
forming Ala-Gln, and no Gln-Ala.31 The dipeptide Ala-Ala was also formed by BacD, but no 
tripeptides were observed by LC-MS.31 Unlike BacD, BL00235 has a narrow substrate 
specificity where the N-terminal substrate is limited to L-Met and L-Leu and the C-terminal 
substrate is limited to L-Ala, L-Ser, L-Thr, and L-Cys.30 This difference is interesting 
considering the structural similarity between the two enzymes, with a root-mean-square 
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difference (r.m.s.d.) between 372 corresponding Cα atoms in the enzymes of only 2.71 Å.30 
BL00235 has a deep substrate-binding pocket, and comparison with BacD suggests the 
dipeptide-binding site is located on top of this pocket.30 Further comparison with BacD 
revealed that critical residues for enzymatic activity of BL00235 include Arg290 and Gly293,  
and necessary residues for recognition of the N-terminal substrate amine include Glu325 and 
His271.30 Conversely, Ser294 is necessary for recognition of the C-terminal carboxyl in 
BL00235, but this is not conserved in BacD, which requires Gly14, Tyr238, Val296, Ile340, 
Tyr386, and Phe389, and thus forming a hydrophobic cavity.30 The N-terminal preference of 
BL00235 is due to this hydrophobic cavity, accepting L-Met and L-Leu as substrates, and the 
N-terminal preference of BacD is due to the presence of bulky hydrophobic sidechains in the 
hydrophobic cavity, allowing only small residues such as Gly and L-Ala to enter.30 Substrate 
specificity for the C-terminal amino acid is likely controlled by Phe83, Pro85, and Phe156 of 




Figure 1.7. Crystal structures of BacD, BL00235, and RizA. (A) Alignment of the crystal 
structures of BacD (red; PDB 3VMM) and BL00235 (blue; PDB 3VOT) shows structural 
similarity between the enzymes. (B) Alignment of the crystal structures of BacD (red) and 
RizA (green; PDB 4WD3) shows structural similarity between the enzymes. 
 
Similar to both BacD and BL00235 is RizA, which is an ATP-grasp enzyme involved 
in synthesizing the antifungal linear compound rhizocticin A in Bacillus subtilis and has an 
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overall similar structure to those of both BL00235 and BacD (Fig. 1.7B).32, 35-37 The respective 
domains are composed of amino acids 1-121 (N), 122-195 (B), and 196-413 (A+C) in RizA 
and are essentially identical in BacD and BL00235.37 However, superposition of RizA with 
BacD and BL00235 showed poor alignment between large regions of α-helices and β-strands 
of all three domains.37 Over 1368 atoms, r.m.s.d. between BacD and BL00235 was 2.195 Å, 
but r.m.s.d. values between RizA and BacD and between RizA and BL00235 were 5.274 Å 
and 6.124 Å, respectively.37 Speculation led to the idea that these larger r.m.s.d. values result 
from the lack of ADP binding in the crystal structure of RizA.37 The structure of BacD revealed 
Lys138, Lys178, Glu226, Glu311, and Glu324 interact with ADP by hydrogen bonding, and 
these residues are conserved in BL00235 and RizA as well, therefore the ATP-binding pocket 
is conserved in all three of these L-amino acid ligases.37 Substrate recognition by BacD is due 
to Leu12, Trp76, Leu110, Glu273, Glu311, Glu324, and Arg328, and the latter three residues 
are bound to the peptide bond of the substrate and are conserved in BL00235 and RizA.37 
However, Leu12, Leu110, and Glu273 recognize the sidechains of the dipeptide substrate and 
are not conserved in BL00235 or RizA.37  
Since BacD, BL00235, and RizA have been shown to exhibit different substrate 
specificities, residues conferring substrate-binding pockets for each enzyme likely vary.37 
RizA shows high N-terminal substrate specificity towards L-Arg, linking it to various amino 
acids.36 The RizA putative substrate binding pocket is a hydrophobic cavity able to 
accommodate a large amino acid such as Arg, and the hydrophobic residues likely interact 
with the hydrocarbon portion of the sidechain of Arg.37 These reported crystal structures 




1.4 FUTURE PROSPECTS 
 More research is needed to fully analyze substrate scope of these enzymes. If enough 
ATP-grasp enzymes are analyzed to characterize their accepted substrates and crystallized to 
identify residues necessary for substrate binding, a database can be made. From there, a 
prediction algorithm can potentially be generated to suggest possible chemistry for each ATP-
grasp enzyme by aiding substrate predictions, similar to existing prediction software used for 
NRPS enzymes.  
ATP-grasp enzymes can be used as a search query for genome mining to identify novel 
natural products. Many NRPS-synthesized natural products have been elucidated through 
genome mining efforts, but not many ATP-grasp synthesized natural products have. The ATP-
grasp enzyme FtyB from Pseudoalteromonas tunicata catalyzes the condensation of L-Thr and 
3-formyl- L-Tyr to form the natural product 3-formyltyrosine-threonine.38 This molecule was 
discovered through homology searching using the dapdiamide ATP-grasp enzyme DdaF as a 
query, but bioactivity of this molecule has not yet been reported.38 In depth studies of FtyB 
substrate scope have also not been reported, so it is unclear whether other substrates could be 
accepted by this enzyme. This genome mining method would likely lead to novel natural 
products with potential bioactivity. 
 Finally, this class of enzymes presents a new method for drug development or 
synthesis. The ability of these enzymes to catalyze amide bonds could lead to faster synthetic 
routes than total synthesis and may be simpler to use than solid-phase peptide synthesis. In 
particular, TabS could be used to generate many different dipeptides due to its lax substrate 





CHAPTER 2: PHEVAMINE A AND MANGOTOXIN: SMALL MOLECULES 
PRODUCED BY PSEUDOMONAS SYRINGAE THAT AFFECT PLANT 
INFECTIONS 
 
The work on phevamine A was completed in collaboration with Tatiana Mucyn and Jeff Dangl at UNC. They 
created genetic knockouts of the hsv cluster and performed all plant assays with Pto and the phevamines. 
Phylogenetic analysis of hsv was conducted by Omri Finkel. Chemical synthesis of phevamine A was 
conducted by Jon Patteson and Elisabetta Massolo. 
 
2.1 INTRODUCTION 
 Bacterial small molecules play key roles in pathogen–plant interactions. Pseudomonas 
syringae, a phylogenetically diverse species of bacteria responsible for many crop diseases, 
deploys a myriad of virulence factors, including secreted protein effectors delivered to host 
cells by the type III secretion system (T3SS) and small molecules.39-40 Coronatine, 
syringomycin, syringopeptin, tabtoxin, and phaseolotoxin are among the small molecule 
virulence factors produced by various strains of P. syringae, acting as phytohormone mimics 
or phytotoxins.39 For example, coronatine disrupts plant immune signaling by mimicking the 
structure of the plant hormone jasmonic acid-isoleucine,39, 41 and phaseolotoxin contributes to 
virulence by interfering with the synthesis of L-arginine and polyamines.42-43 While many 
protein effectors have been extensively studied in P. syringae, only a limited number of small 
molecules have been identified. The genomes of P. syringae and other phytopathogens encode 
potential biosynthetic enzymes.44-45 Identifying the cryptic small molecules synthesized by 




 Many phytopathogenic virulence factors function to suppress plant immune 
responses.46-47 The first layer of the plant immune system relies on the recognition of conserved 
microbe-associated molecular patterns (MAMPs) by host pattern recognition receptors to 
generate MAMP-triggered immunity (MTI).48 The MTI signaling cascade includes receptor 
kinase activation, reactive oxygen species (ROS) production, calcium influx, mitogen-
activated protein kinase (MAPK) activation, defense gene activation, and callose deposition at 
the plant cell wall (Fig. S2.1); each of these steps can be targeted by virulence factors.48 The 
sigma factor HrpL controls the expression of P. syringae virulence factors including the T3SS 
and its associated effector genes.49 HrpL also regulates genes responsible for the biosynthesis 
of coronatine in some, but not all, P. syringae strains.13, 50 Our recent study identified a number 
of uncharacterized HrpL-regulated genes that encode putative biosynthetic enzymes for small 
molecules.13 We therefore proposed that these HrpL-regulated genes are responsible for 
synthesizing small molecules that play a role in virulence.13 
In this chapter, we focus on two biosynthetic operons: the HrpL-regulated three-gene 
cluster PSPTO_0873–0875 from P. syringae pv. tomato DC3000 (Pto),13, 51 and the six-gene 
cluster mboA–F from P. syringae pv. syringae UMAF0158 (UMAF).14 The Pto operon shares 
66-85% homology with hrp (hypersensitive response and pathogenicity)-associated systemic 
virulence (hsv) genes from Erwinia amylovora.52 The Pto hsv operon was implicated in the 
virulence of E. amylovora on apple shoots,53 but the small molecule(s) produced by hsv-
encoded enzymes were unknown. The mangotoxin biosynthetic operon, mboA–F, shares 26–
27% sequence identity with the proteins encoded by the Pto hsv cluster. Mangotoxin, 
synthesized by the enzymes encoded in the mbo cluster, is an antimetabolite that inhibits plant 
ornithine N-acetyl transferase, an essential enzyme for ornithine and arginine biosynthesis.15 
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The bioactivity of mangotoxin was reported in 2003 and the mbo cluster was identified in 2012, 
however, the structure of mangotoxin still remains unknown.14-15 
Here, we confirm that the Pto hsv operon acts as a P. syringae virulence factor on 
Arabidopsis thaliana and demonstrate that the hsv operon dampens host immune responses in 
both A. thaliana and Nicotiana benthamiana. We demonstrate that the enzymes encoded by 
the hsv operon synthesize a small molecule that is important for virulence. By integrating 
heterologous expression, metabolomics, and in vitro biosynthesis, we identify a novel 
bioactive small molecule, phevamine A, the conjugate of L-phenylalanine, L-valine and a 
modified spermidine. We further show that phevamine A suppresses the potentiation of 
MAMP-induced ROS bursts by spermidine and L-arginine. Thus, phevamine A is a new small 
molecule virulence factor that promotes bacterial growth and virulence, in part by suppressing 
plant immune response. We also show that the hsv and mbo enzymes share fairly high (~27%) 
sequence identity, but they prefer different substrates and therefore likely synthesize different 
small molecules.  
 
2.2 RESULTS AND DISCUSSION 
2.2.1 The P. syringae hsv operon promotes virulence and suppresses defense responses.  
To investigate the function of the hsv operon, we first generated independent clean 
deletion mutants in Pto. The parental strain, Pto, and the two mutants, Pto_∆hsv1, Pto_∆hsv2 
were used to infect A. thaliana Col-0 seedlings by dip inoculation and monitor bacterial 
growth. We observed that the mutants grew slightly less than the Pto strains (Fig. S2.2) in two 
independent experiments, but this reduced growth trend was not statistically significant. This 
observation is not surprising, as Pto is an aggressive pathogen on A. thaliana and its large suite 
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of virulence factors can act collectively.54 It is therefore rare to observe significant loss of 
virulence phenotypes when deleting a single candidate virulence factor from this strain. To 
circumvent this problem, we used a weakly pathogenic Pto derivative deficient in coronatine 
production (Pto DC3118, hereafter Pto-Cor -)54 to generate independent hsv mutants Pto-Cor - 
Δhsv1, and Pto-Cor - Δhsv2. Three days post-infection, significantly less bacteria for Pto-Cor 
- Δhsv1 and Pto-Cor - Δhsv2 were recovered from the seedlings than Pto-Cor - (Fig. 2.1A). This 
result indicates that hsv is required for full virulence in planta.  
We next addressed whether the hsv operon had an effect on host callose deposition, a 
cell wall reinforcing response typically triggered during MTI (Fig. S2.1).55-56 Several type III 
secretion effector proteins can inhibit callose deposition57-61 and thus may obscure phenotypes 
resulting from hsv deletion. We therefore generated two independent hsv clean deletions in 
PtoD28E (PtoD28EΔhsv1 and PtoD28EΔhsv2), a strain lacking 28 different type III secretion 
effectors.62 PtoD28E, PtoD28EΔhsv1 and PtoD28EΔhsv2 were used to infiltrate four-week-
old leaves of A. thaliana. Both PtoD28EΔhsv alleles induced higher callose deposition than 
PtoD28E (Fig. 2.1B); complementation of PtoD28EΔhsv2 with constitutively expressed hsv 
reduced the level of callose back to that induced by PtoD28E (Fig. 2.1C). These results 




Figure 2.1. The hsv operon is required for virulence and suppresses defense responses. 
(A) Pto-Cor -Δhsv mutants display reduced growth on A. thaliana seedlings compared to Pto-
Cor -. This experiment was repeated three times with similar results. (B) PtoD28EΔhsv mutants 
induce higher callose deposition than PtoD28E on 4-week-old A. thaliana leaves. The 
experiment is a representative of 4 independent replicates. (C) Complementation of 
PtoD28EΔhsv2 in PtoD28EΔhsv2 + NptII::hsv re-establishes callose deposition to levels 
triggered by PtoD28E. This assay is a representative of two independent replicates. (D) The 
hsv operon suppresses callose deposition when co-expressed in Pf0-1 with T3SS, but not when 
expressed in Pf0-1. The callose deposition was monitored as in (B) after infiltration of Pf0-1 
or Pf0-1 expressing hsv. This assay was performed twice with similar results. Pf0-1+T3SS and 
Pf0-1+T3SS expressing hsv were tested separately with at least three replicate experiments for 
each strain. (E) The hsv operon in Pf0-1 suppresses T3SS-mediated cell death in N. 
benthamiana. Pf0-1 derived strains were inoculated at three different concentrations (cfu/mL). 
Pictures were taken 20 hours post-infiltration. This assay was repeated 4 times with similar 
results. ** indicates t-test, p value < 0.01. Error bars represent ± standard error. Cfu/mg: colony 
forming units per milligrams of plant tissue. Relative callose intensity represents the number 
of callose deposits observed per field.  
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Conversely, we also examined whether hsv expression is sufficient to suppress plant 
callose deposition induced by a non-pathogenic bacterium. The hsv operon was constitutively 
expressed in Pseudomonas fluorescens Pf0-1 (Pf0-1), a strain that lacks both hsv and a type III 
secretion system (T3SS), but still induces callose deposition (Fig. 2.1D).63 Expression of hsv 
had no effect on the level of Pf0-1-induced callose deposition (Fig. 2.1D). A Pf0-1 derivative 
engineered to contain a complete P. syringae T3SS locus (Pf0-1+T3SS)64 induced more callose 
than wildtype Pf0-1 (Fig. S2.3), suggesting that Pf0-1 T3SS components are recognized by the 
plant.65 Expression of hsv in the Pf0-1+T3SS strain reduced the level of callose back to the 
level elicited by wildtype Pf0-1 (Fig. 2.1D, Fig. S2.3). Thus, hsv suppresses the callose 
deposition induced by Pf0-1 T3SS components. To extend this observation, we evaluated the 
activities of these P. fluorescens strains on a second plant species, Nicotiana benthamiana. 
Infiltration of N. benthamiana leaves with Pf0-1 or Pf0-1 expressing hsv had no effect; the 
tissue infiltrated with bacteria was identical to the non-infiltrated tissue (Fig. 2.1E). In contrast, 
infiltration with Pf0-1+T3SS elicited a dose-dependent leaf cell death. This response was 
suppressed by hsv expression (Fig. 2.1E). Thus, hsv suppresses the cell death caused by a 
component of the T3SS or the linked harpin gene transferred from P. syringae pv. syringae to 
Pf0-1.66-67 
 
2.2.2 hsv-encoded enzymes synthesize three related small molecules. 
The hsv operon encodes three enzymes, including a putative amidinotransferase HsvA 
and two putative ATP-grasp type enzymes HsvB and HsvC (Fig. 2.2A). To test the hypothesis 
that these hsv-encoded enzymes synthesize small molecules, we conducted hsv heterologous 
expression and comparative metabolomics experiments. The hsv cluster was overexpressed in 
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E. coli as a heterologous host to enhance small molecule production. Organic extracts of 
culture supernatants were analyzed using liquid chromatography-coupled high-resolution mass 
spectrometry (LC-HRMS) to generate metabolomic profiles for comparison. Three species 
with mass-to-charge ratios (m/z) of 287.255, 434.324, and 581.392 were present at high levels 
in the hsv-expressing E. coli, but were absent in the control E. coli carrying the empty vector 
(Fig. 2.2B, Fig. S2.4–2.6). The species with the m/z of 287.255 and 434.324 were also detected 
by LC-HRMS in the culture extract of the wildtype Pto, but not in Pto∆hsv (Fig. 2.2C, Fig. 
S2.5). The production of the metabolite with the m/z of 434.324 is also observed in Pto 
overexpressing hrpL, but is reduced by hrpL deletion (Fig. 2.2C), consistent with the regulation 
of hsv by hrpL.13 This metabolite was detected at the same level in the supernatants of both 
Pf0-1 and Pf0-1+T3SS expressing hsv (Fig. S2.7), indicating that secretion of the compound 






Figure 2.2. Metabolomics reveal the small molecules synthesized by hsv-encoded 
enzymes. (A) Graphical representation of the hsv operon. (B) Comparative metabolomics 
analysis in E. coli. Overexpression of hsv produces a new peak with a mass-to-charge (m/z) 
ratio of 434.324 (green), which is absent in E. coli harboring the empty vector (red). (C) 
Comparative metabolomics analysis in Pto. The molecule with the m/z of 434.324 is absent in 
Δhsv (green) and reduced in ΔhrpL (red), but present in both wildtype Pto (blue) and Pto 
overexpressing hrpL (maroon). Extracted ion chromatogram for 434.324 is shown in (B) and 
(C). The slight change in retention time is due to the hydrophilic nature of this molecule. 
Experiments presented in (B) and (C) were repeated at least 3 times. 
 
We analyzed the structures of the identified metabolites from E. coli and P. syringae 
strains expressing the hsv operon by tandem MS, which revealed that these metabolites share 
similar MS fragments (Fig. S2.8, Fig. S2.9) and likely possess related structures. The mass 
differences between 287.255 and 434.324, and between 434.324 and 581.392 are both 147.068, 
corresponding to the mass of a phenylalanine in an amide linkage. Based on these data, we 
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propose that the structures of the compounds with the m/z of 434.324 and 581.392 contain one 
and two phenylalanines, respectively. We name the identified metabolites phevamine A (m/z 
434.324; PHVA), phevamine B (m/z 581.392; PHVB) and pre-phevamine (m/z 287.255; 
pPHV).  
 
2.2.3 In vitro biosynthesis of phevamines reveals novel structures. 
To characterize the structures of phevamines, we reconstituted the biosynthetic 
enzymes encoded by the hsv operon in vitro. HsvA shares homology with amidinotransferases 
that transfer an amidino group from arginine to an amine, suggesting the presence of an 
amidino group. HsvB and HsvC belong to the ATP-grasp enzyme superfamily consisting of 
ATP-dependent enzymes that condense carboxylic acids with amines, suggesting the presence 
of amide linkages in the phevamines and pre-phevamine.1 HsvA, HsvB, and HsvC were 
overexpressed in E. coli and purified as recombinant proteins. We reconstituted the activity of 
HsvA by incubating L-arginine, the donor of the amidino group for amidinotransferases, in the 
presence of a variety of physiologically relevant amines as acceptors, including L-lysine as 
well as spermidine and spermine, which are polyamines produced by P. syringae.68-69 We 
found that HsvA preferentially modifies spermidine and generates amidinospermidine (Fig. 
2.3A, Fig. S2.10, Fig. S2.11). Subtracting the mass of amidinospermidine from that of pre-
phevamine results in a mass consistent with a valine in an amide linkage. We therefore 
proposed amidinospermidine is condensed with L-Val as the second biosynthetic step to 
generate pre-phevamine (Fig. 2.3A). Both ATP-grasp enzymes, HsvB and HsvC, were 
examined for this condensation activity in the presence of amidinospermidine, L-Val, ATP and 
Mg2+. Only HsvC catalyzes pre-phevamine formation (Fig. 2.3A, Fig. S2.10). Data from LC-
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HRMS analyses and phosphate release assays suggest that L-phenylalanine is a structural 
component of the phevamines (Fig S2.12). To validate this proposal, we incubated pre-
phevamine with HsvB and L-Phe, and the formation of phevamine A and phevamine B was 
indeed observed (Fig. 2.3A, Fig. S2.10, Fig. S2.13). This result also indicates that HsvB can 
catalyze two rounds of condensation with L-Phe. Tandem MS analysis of phevamine A 
suggests that the amidino group is connected to the propylamine end of spermidine (Fig. 2.3B, 
Fig. S2.9).  
 
Figure 2.3. Structural characterization and biosynthesis of pre-phevamine and 
phevamines. (A) Biosynthetic pathway of pre-phevamine and the phevamines based on in vitro 
characterization. (B) Structural analysis of phevamine A produced by E. coli overexpressing 
hsv using tandem MS. (C) (1H,13C)-HMBC correlations of in vitro synthesized and purified 
phevamine A. (D) Extracted ion chromatogram of phevamine A (m/z, 434.324) produced via 
in vitro enzymatic synthesis (blue) or total chemical synthesis (green).  
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Having identified that phevamines consist of L-Phe, L-Val, and amidinospermidine, we 
next determined the connectivity of these components by NMR analysis. Due to high polarity, 
phevamines were difficult to isolate from bacterial culture extracts. To isolate sufficient 
materials for NMR, we developed in vitro biosynthetic methods for phevamine A and 
phevamine B. From 16 mL of in vitro enzymatic assays, 5.7 mg of phevamine A and 5.5 mg 
of phevamine B were purified. These compounds were analyzed by 1H, (1H,1H)-COSY, 
(1H,13C)-HMBC, and (1H,13C)-HSQC NMR experiments (Fig. 2.3C and Fig. S2.14–2.21). The 
NMR data supports that the amidino group is linked to the propylamine side of spermidine and 
that phevamine B contains an additional L-Phe at the N-terminus of phevamine A. Phevamine 
B was only detected under conditions of heterologous expression and in vitro synthesis, but 
not in the culture extract of Pto (Fig. S2.6), suggesting that phevamine B is unlikely a 
physiologically relevant molecule. The production of phevamine B may be due to the 
overexpression of HsvB in E. coli and the high concentration of HsvB and L-Phe added in 
vitro. Thus, we focused on phevamine A for further structural characterization. To confirm the 
relative stereochemistry, we developed a total synthesis method for phevamine A. Synthetic 
and in vitro isolated phevamine A exhibit identical 1H and 13C NMR signals, and the same LC 
retention time and MS fragmentation pattern as the species detected in the bacterial culture 
extract (Fig. 2.3D, Fig. S2.14–2.22). These results confirmed the structure assignment for 
phevamine A and provided materials for biological activity testing of this molecule. In an 
initial activity test, we examined the ability of phevamine A to bind ferric iron using a 
chromeazurol S assay and observed no significant binding to ferric iron (Fig. S2.23), 




2.2.4 Comparative genomics suggests a potential host target for phevamines. 
We investigated the phylogenetic distribution of hsv in bacterial genomes using 
MultiGeneBlast that identifies homologous gene clusters based on sequence similarity and 
gene synteny.70 We found that hsv is widely distributed across plant-pathogenic bacterial 
genera including Pseudomonas, Erwinia, and Pantoea. We compared the distribution of the 
hsv operon to those biosynthetic gene clusters encoding known P. syringae phytotoxins, 
focusing on coronatine, mangotoxin, phaseolotoxin, tabtoxin, and syringolin (Fig. 2.4A; Table 
S2.1).39, 71 The hsv operon is present in ~36% of P. syringae (107 out of 292) and is the most 
widely-distributed gene cluster of the six analyzed. The hsv operon rarely co-occurs with any 
of the aforementioned small molecule biosynthetic clusters. This anti-correlation is especially 
prominent between hsv and phaseolotoxin biosynthetic genes in the genomes of otherwise 
extremely closely related strains of P. syringae pv. actinidiae.72 We previously showed that 
functionally redundant virulence factors rarely co-occur in the same strain.73 Specifically, the 
small molecule coronatine and three different type III secretion system protein effectors use 
four distinct mechanisms to target the same host defense signaling pathway, and only genes 
responsible for a single mechanism are typically found in any given P. syringae genome.73 
Based on the clear anti-correlation of hsv with the phaseolotoxin biosynthetic genes, and the 
knowledge that phaseolotoxin targets host arginine and polyamine biosynthesis by inhibiting 
ornithine carbamoyltransferase and ornithine decarboxylase (Fig. 2.4B),42-43, 74 we 
hypothesized that the action of phevamine A involves polyamines and/or arginine. This 
hypothesis is consistent with previous implication of polyamine function in plant immune 
responses.75-76 Furthermore, our genomic analysis revealed that many P. syringae strains do 
not contain the biosynthetic gene clusters for phevamine A or the five other phytotoxins 
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described herein (Fig. 2.4A). These strains could produce different small molecules that might 
play a role in bacteria–plant interaction. 
 
Figure 2.4. Distribution of the hsv operon and other toxins among P. syringae and 
graphical representation of polyamine biosynthesis and action of phaseolotoxin. (A) 
Phylogenetic tree of 292 P. syringae strains and the distribution of coronatine, mangotoxin, 
phevamine A, syringolin, phaseolotoxin, and tabtoxin biosynthetic genes, from the outer ring 
to the inner ring. The tree scale represents the nucleotide substitution per site. (B) 
Phaseolotoxin inhibits the arginine and polyamine pathways by suppressing the activity of 
ornithine decarboxylase (ODC) and ornithine carbamoyltransferase (OCT). ADC: arginine 
decarboxylase, SPDS: spermidine synthase, SPMS: spermine synthase. Double dashed arrows 
represent pathways with intermediates not shown. Adapted from 77.  
 
2.2.5 Polyamines and arginine potentiate an early MTI response.  
We investigated the effect of arginine and polyamines on the MTI response induced by 
the well-studied MAMP flg22, a short peptide derived from the Pseudomonas flagellin.55 We 
monitored the ROS burst following recognition of flg22 by the pattern recognition receptor 
FLS2 (Fig. S2.1).78-79 The polyamines putrescine, spermidine, and spermine potentiated the 
flg22-induced ROS burst in N. benthamiana, resulting in an earlier and larger amplitude 
response (Fig. 2.5A, Fig. 2.5B, Fig. S2.24A). The potentiation was dose-dependent (Fig. 
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S2.24B). Spermidine alone induced only a slight ROS burst (Fig. S2.24C),76 and the increase 
of the flg22-induced ROS burst in the presence of spermidine was higher than an additive 
effect (Fig. S2.24C). The potentiation by spermidine was also observed in A. thaliana, but was 
not observed in the flg22 receptor mutant fls2 (Fig. 2.5C, Fig. S2.25A, Fig. S2.25B). 
Spermidine potentiation was also observed using the elicitor elf18 (Fig. S2.25C).80 
Surprisingly, the Arabidopsis Ca++ burst induced by flg22 was reduced in the presence of 
spermidine (Fig. 2.5D, Fig. S2.1, Fig. S2.25D). Arginine had a similar effect on this early MTI 
response, while L-citrulline did not (Fig. S2.26, Fig. S2.27). Thus, spermidine and arginine 
potentiate MAMP-induced ROS bursts in both plant species, and spermidine modulates the 
flg22-induced Ca++ burst, at least in A. thaliana. These results are consistent with previously 
proposed functions of polyamines in plant defense responses,75-76 including upregulation of 
polyamine biosynthesis in plants following challenge with bacterial pathogens,81-84 subsequent 
polyamine transport to the apoplast,81 and increased resistance toward Pseudomonas 
viridiflava observed after exogenous addition of spermine.84  
 
2.2.6 Phevamine A suppresses spermidine and arginine potentiation of the flg22-induced 
ROS burst. 
The anti-correlation of phevamine A and phaseolotoxin production suggested that 
phevamines might impair the effect of spermidine and arginine on the early MAMP-dependent 
ROS burst. We therefore tested whether phevamine A could impair the effect of exogenously 
supplied spermidine and arginine in the MTI-induced ROS burst potentiation assay. Leaf disks 
of N. benthamiana were challenged with flg22 in the presence of phevamine A, spermidine, or 
both (Fig 2.5A). We observed that phevamine A suppressed the spermidine potentiation of the 
flg22-induced ROS burst in N. benthamiana, but did not directly affect the flg22 response (Fig. 
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2.5A). We noted that pre-phevamine also suppressed the spermidine potentiation of the flg22-
induced ROS burst, but phevamine B did not (Fig. 2.5B). This result is consistent with our 
observation that phevamine B is not naturally produced by Pto (Fig. S2.6). In contrast, only 
phevamine A suppressed the spermidine-mediated flg22-induced ROS burst in A. thaliana leaf 
disks in a similar experimental set up (Fig. 2.5C). This indicates that the molecular 
mechanism(s) of the spermidine potentiation might differ slightly between N. benthamiana 
and A. thaliana.  
 
Figure 2.5. Effect of the phevamines and pre-phevamine on the spermidine potentiation 
of the ROS burst and suppression of the calcium burst. (A) Phevamine A suppresses the 
spermidine potentiation of the flg22-induced ROS burst in N. benthamiana, but does not affect 
the flg22-induced ROS burst directly. Leaf disks were treated with 50 nM flg22, with or 
without spermidine at 400 µM, and with or without phevamine A at 400 µM. (B) Phevamine 
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A and pre-phevamine suppress the spermidine potentiation in N. benthamiana, but phevamine 
B does not. Leaf disks were treated with flg22 at 10 nM, spermidine, phevamines and pre-
phevamine were used at 300 µM. (C) In Arabidopsis, phevamine A suppresses the spermidine 
potentiation, while pre-phevamine does not. Leaf discs were treated with flg22 at 10 nM, 
spermidine and phevamines were used at 300 µM. (D) Phevamine A does not affect the flg22-
induced Ca++ burst, or the reduction of this burst by spermidine. Leaf disks were treated with 
flg22 at 20 nM, spermidine and phevamine A were used at 300 µM. Error bars represent 
standard errors. Relative luminescence units: RLU, phevamine A: PHVA, phevamine B: 
PHVB, pre-phevamine: pPHV, Spermidine: Spd. All experiments presented here were 
repeated at least 3 times. 
 
Spermidine affects both the flg22-induced ROS and Ca++ bursts (Fig. 2.5D, Fig. 
S2.24C). We therefore tested the effect of phevamine A on the flg22-induced Ca++  burst in the 
presence and absence of spermidine using a transgenic A. thaliana line that expresses the 
aequorin reporter.85 As noted above, spermidine suppressed the flg22-induced Ca++ burst, but 
the addition of phevamine A did not affect this suppression. Phevamine A also had no direct 
effect on the Ca++ burst induced by flg22 (Fig. 2.5D). These data suggest that phevamine A 
acts downstream of the Ca++ burst. 
Additionally, both phevamine A and pre-phevamine were tested for their effect on the 
ROS potentiation mediated by arginine in both N. benthamiana and A. thaliana. Phevamine A, 
but not pre-phevamine, could suppress the arginine-mediated potentiation of the flg22-induced 
ROS burst in N. benthamiana (Fig. S2.27). This may imply that the potentiation mediated by 
spermidine and arginine in N. benthamiana involves slightly divergent molecular 
mechanism(s), supported by the different potentiation phenotypes for pre-phevamine. 
Similarly, only phevamine A and not pre-phevamine could inhibit the arginine potentiation of 
the flg22-induced ROS burst in A. thaliana.   
 
33 
Overall, we observed that phevamine A consistently suppressed both the spermidine- 
and arginine-mediated potentiation of the flg22-induced ROS burst across two divergent plant 
species. Thus, phevamine A is likely the most physiologically relevant small molecule 
produced by the hsv operon in Pto. 
 
2.2.7 In vitro reconstitution of mbo enzyme activity reveals different substrate preferences 
from hsv enzymes. 
 To elucidate the structure of mangotoxin, we purified the biosynthetic enzymes MboB, 
MboC, MboD, and MboE for in vitro enzyme assays (Fig 2.6). Similar to the hsv enzymes, 
MboC and MboD are putative ATP-grasp enzymes and MboE is a putative amidinotransferase. 
MboB is likely a (2Fe-2S)-containing ferredoxin oxidoreductase based on sequence homology. 
We have shown that the amidinotransferase HsvA catalyzes transfer of the amidino group from 
L-Arg to spermine, spermidine, and L-Lys.12 MboE was also tested for amidinotransferase 
activity by combining L-Arg, the typical amidino donor, with L-Lys, L-Cys, L-Ala, Gly, 
spermine, or spermidine, but no products from the transfer of the amidino group were observed 
in the presence of these substrates. Therefore, MboE likely performs different reactions or 
modifies different substrates from HsvA. Also, since spermidine, glycine, and lysine are the 
only reported amine acceptors for amidinotransferase enzymes, it is unclear what the native 
substrate of MboE is. Additionally, deletion of mboE in UMAF0158 only decreased 
mangotoxin production slightly and did not diminish the production fully, therefore MboE is 




Figure 2.6. Graphical representation of the mbo operon. The mbo gene cluster encodes an 
amidinotransferase (green), two ATP-grasp enzymes (blue), and an oxidoreductase (red). 
 
 The mbo cluster encodes two ATP-grasp enzymes, MboC and MboD, like the hsv 
cluster, so we predict that mangotoxin also contains two amide bonds. To identify the 
substrates of MboC and MboD, all proteinogenic amino acids were screened in vitro as 
potential substrates. Based on LC/MS analysis, MboC catalyzes the formation of the following 
L-amino acid peptides: Arg-Ala, homoarginine (hArg)-Ala, hArg-Cys, Arg-Ala-Leu/Ile, Arg-
Ala-Lys, Arg-Ala-Met, hArg-Ala-Val, hArg-Ala-Leu/Ile, and hArg-Ala-Met (Fig. 2.7A, 2.7B, 
Fig. 2.8A–C). However, the activity of MboD could not be reconstituted in the presence of the 
20 canonical amino acids or spermine, spermidine, ornithine, or homoarginine. This result 
suggests that MboD acts on a nonproteinogenic amino acid or an amino acid that is modified 
first by MboB, or a peptide generated by MboC, which can catalyze the formation of several 
di- and tripeptides from free amino acids. Interestingly, MboC formed three times as much 
hArg-Ala than Arg-Ala. If MboE could act on L-Lys as a substrate first to form hArg, then 
MboC could form the hArg-Ala dipeptide, but MboE is not able to catalyze this reaction. 
Further, the Arg-Ala-Ala dipeptide was observed in the presence of both MboE and MboC, 
but not in the presence of MboC alone. Therefore, MboE may act as a chaperone for or 
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complements MboC, consistent with the observation that deleting mboE reduced mangotoxin 
production, but did not completely diminish it.  
 
Figure 2.7. Preliminary phosphate release colorimetric assays suggest the substrate scope 
of MboC. The amino acid pairs listed were incubated with the necessary cofactors without (-) 
or with (+) MboC. Darker assays show release of free phosphate, suggesting enzyme activity. 
Assays showing the darkest colors were analyzed by LC-MS to confirm formation of the 




Figure 2.8. MboC catalyzes the formation of di- and tri-peptides in the presence of all 20 
canonical amino acids in vitro. EICs from LC-MS analyses are shown for each di- or 
tripeptide. Reactions contained all 20 canonical amino acids either with or without MboC. (A) 
Dipeptides formed in the presence of MboC (red spectra). Black spectra are EICs from the no 
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MboC control reaction. (B) Tripeptides formed from MboC and the Arg-Ala dipeptide (red 
spectra). Black spectra are EICs from the no MboC control reaction. (C) Tripeptides formed 
from MboC and the hArg-Ala dipeptide (red spectra). Black spectra are EICs from the no 
MboC control reaction. 
 
To obtain general rules for ATP-grasp enzyme substrate specificity, sequence 
similarity networks (SSN) were generated. Amino acid sequences were obtained from NCBI 
and analyzed using the EFI-EST web-tool. When the ATP-grasp enzymes from the phevamine, 
mangotoxin, tabtoxin, dapdiamide, rhizocticin, and bacilysin biosynthetic pathways were the 
only enzymes included, the grouping appeared to correlate with the producing strain, 
suggesting phylogeny is the dominant factor for ATP-grasp sequence (Fig. 2.9A-C). 
Significantly increasing the E-value for network generation resulted in slightly more edges 
between nodes (Fig. 2.9A). A larger network was then generated using a BLAST search of all 
ATP-grasp enzymes. To visualize this network on a regular computer, stringent parameters 
needed to be set using the program Cytoscape. Interestingly, phylogeny still appeared to be the 
most dominant factor in ATP-grasp sequence. Also, the substrate scope within a single ATP-
grasp enzyme can vary drastically, for example the ATP-grasp enzyme TabS involved in 
tabtoxin biosynthesis can generate 136 different dipeptides.10 Therefore, many more ATP-
grasp enzymes need to be studied and characterized in terms of their structures and substrate 




Figure 2.9. ATP-grasp sequence similarity networks group by phylogeny. Sequence 
similarity networks were generated using EFI-EST and were visualized in Cytoscape. When 
the E-value was decreased, the number of edges between nodes also decreased. HsvB and 
HsvC are in the phevamine pathway, MboC and MboD are in the mangotoxin pathway, RizA, 
RizB, and BL00235 are in the rhizocticin pathway, YwfE is in the bacilysin pathway, DdaF is 
in the dapdiamide pathway, and TabS is in the tabtoxin pathway. 
   
2.2.8 Activity-guided fractionation of UMAF0158 extracts suggests mangotoxin is unstable. 
 Mangotoxin is known to inhibit plant ornithine N-acetyl transferase (OAT), thus this 
bioactivity can be used to track the molecule for extraction and purification. One way to track 
OAT activity is by E. coli growth inhibition, because E. coli harbors an N-acetylornithinase 
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that is inhibited by mangotoxin, and this effect can be reversed by supplementation with 
ornithine.15 A second way to assess OAT activity is through an in vitro assay using crude plant 
extract containing the OAT enzyme. The reaction catalyzed by OAT is reversible and involves 
transfer of an acetyl group from N-acetyl-L-Glu (NAcGlu) to L-Orn or N-acetyl-L-Orn 
(NAcOrn) to L-Glu. Therefore, incubating plant OAT with L-Glu and NAcOrn will form L-
Orn and NAcGlu as products. Addition of the UMAF extract containing mangotoxin to the 
reaction will inhibit the activity of OAT and prevent formation of Orn and NAcGlu. Based on 
this activity assay design, we grew UMAF cultures and extracted polar metabolites, since 
mangotoxin is likely a short peptide, and fractionated the extract by preparative HPLC. Each 
fraction was analyzed using both OAT activity detection methods. Indeed, we found that the 
UMAF overnight seed cultures inhibited E. coli growth and plant OAT activity (Fig. 2.10). 
The culture of Pto, which does not produce mangotoxin, was used as a negative control and 
did not exhibit inhibitory activity against E. coli or plant OAT (Fig. 2.10). However, when the 
UMAF cell-free supernatant, extract, or any of the purified fractions was added, no inhibition 
of E. coli growth or plant OAT was observed, suggesting these materials no longer contain 
active mangotoxin. Purified mangotoxin was reported to be unstable and inactive after a few 
hours at room temperature, which likely explains why only the UMAF whole cell culture could 
inhibit E. coli growth and plant OAT activity and purified fractions could not.15 Perhaps the 
oxidoreductase MboB is responsible for an oxidation that causes mangotoxin to be unstable 
under laboratory conditions, which may not be a perfect mimic of the conditions where the 
mbo host, P. syringae, is isolated from. To isolate and purify mangotoxin for structural 
characterization, we will need to identify conditions for culture growth, metabolite extraction, 




Figure 2.10. Mangotoxin inhibits E. coli growth which can be partly rescued by ornithine 
and plant OAT activity. (A) Growth inhibition assays showing UMAF extract inhibits E. coli 
growth, but Pto extract cannot. No growth inhibition was observed in water and KB media 
controls. Zones of inhibition radii are measured and shown for UMAF extracts. When top agar 
was supplemented with Orn (right), the zone of inhibition was reduced in size. (B-H) EICs of 
the N-acetyl-L-Glu product are shown to assess plant OAT activity under various assay 
conditions. (B) Full assay containing UMAF extract. (C) Full assay with DC3000 extract, 
which does not make mangotoxin. (D) Assay without either bacterial extract. (E) Assay 
containing UMAF bacterial extract but no plant extract. (F) Assay containing Pto bacterial 
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extract but no plant extract. (G) Assay without N-acetyl-L-Orn substrate. (H) Assay without L-
Glu substrate. The reaction product is only observed in (C), (D), and (G). 
 
2.3 CONCLUSION AND OUTLOOK 
We identified a new bacterial virulence factor, phevamine A. It is a small molecule, the 
biosynthesis of which is controlled by the HrpL virulence regulator in P. syringae. 
Interestingly, phevamine A shares structural similarity with insect polyamine toxins: 
argiotoxin from the orb-weaver spider, and philanthotoxin from the Egyptian solitary wasp,86 
both of which contain a polyamine and two amino acids, and are powerful neurotoxins that 
target ion channels. The structural similarity suggests related mechanisms, which will be the 
focus of future studies. 
The importance of phevamine A in bacterial virulence has been demonstrated in two 
different pathogens, E. amylovora,53 and P. syringae in this study. We show that the hsv operon 
and purified phevamine A can suppress both early and late markers of plant immune responses. 
Specifically, the hsv operon suppresses T3SS/harpin-induced callose deposition and host cell 
death. The phylogenetic distribution of the hsv operon suggested that phevamine A is a 
conserved virulence factor among bacterial phytopathogens. The anti-correlation of hsv and 
the biosynthetic genes for phaseolotoxin within a closely related clade of P. syrinage pv. 
actinidae genomes suggested functional redundancy between phevamine A and phaseolotoxin. 
We demonstrated that phevamine A impairs plant immune signal potentiation by polyamines 
and arginine, while it is known that phaseolotoxin targets the synthesis of polyamines and 
arginine.  
Our discovery of phevamine A also provided the opportunity to describe new functions 
for polyamines in the potentiation of the MAMP-induced ROS burst induced by flg22, 
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expanding the role of polyamines as important defense mediators. Our results are consistent 
with a model (Fig. S2.28) in which P. syringae uses either phaseolotoxin or phevamine A to 
dampen host immune output by altering polyamine biosynthesis or the signaling capacity of 
polyamines, respectively. We speculate that components of the T3SS and/or harpins may be 
recognized at the cell surface, acting as elicitors of MTI subject to polyamine potentiation and 
suppression by phevamine A. 
Further work will be conducted to characterize the structure of mangotoxin and its 
biosynthesis. The entire mbo cluster has been cloned into an E. coli overexpression vector and 
metabolomics analyses were conducted comparing overexpression with empty vector yielding 
several masses of interest, but it is unclear which is/are biologically relevant molecules. 
Activity of the oxidoreductase MboB will be reconstituted in vitro, likely under anaerobic 
conditions, and other amine acceptors, including the canonical amino acids, will be screened 
for MboE amidinotransferase activity. Concurrently, molecules of interest from metabolomics 
experiments will be analyzed and compared with enzyme assay products to identify the mass 
of mangotoxin. Once masses of interest are identified, several rounds of purification from in 
vitro enzyme assays or culture extract will be conducted in a single day to isolate rapidly pure 
compound for structural analysis by MS/MS and NMR. The purified product will then be 
examined in biological assays, including OAT inhibition and E. coli growth inhibition, but 
again should be conducted immediately after purification to avoid molecule degradation. 
 We show that two ATP-grasp enzymes encoded in the hsv cluster are responsible for 
assembling phevamine A. Preliminary results suggest that two different ATP-grasp enzymes 
encoded in the mbo cluster are responsible for mangotoxin production. These enzymes belong 
to a large superfamily of enzymes that catalyze amide bond formation by activating carboxylic 
 
43 
acids through phosphorylation.87 ATP-grasp-type enzymes are widely used by bacteria for the 
synthesis of diverse small molecules, including the virulence factors phaseolotoxin and 
dapdiamide.11, 16 Studies of these enzymes in a marine proteobacterium and a soil actinomycete 
have led to the discovery of small molecules with distinct structures but unknown functions.38, 
88 Still, most biosynthetic operons containing ATP-grasp-type enzymes have eluded genome-
guided discovery. Our study suggests that targeted mining of uncharacterized ATP-grasp 
enzymes will likely lead to novel small molecules.  
 Our approach for identifying cryptic small molecules builds on the rich knowledge of 
pathogen gene expression and integrates comparative genomic analysis, biochemical enzyme 
reconstitution, and physiological assays. Bacterial genomes harbor many biosynthetic operons 
of unknown function; therefore, this approach holds potential for identifying many more new 
small molecules essential for bacteria–host interactions. 
 
2.4 EXPERIMENTAL PROCEDURES 
2.4.1 General 
All chemicals were purchased from Sigma-Aldrich or Fisher. Primers were ordered 
from Integrated DNA Technology (Table S2.2). Polymerase, restriction enzymes, and ligase 
were purchased from New England Biolabs. DNA manipulation kits were purchased from 
Qiagen and Thermo Scientific. PCR reactions were carried out using an Eppendorf Nexus 
GSX1 thermocycler with Q5 DNA polymerase. General genetic manipulation of E. coli was 
carried out using standard protocols.89 LC-MS data was obtained using an Agilent 6520 
accurate-mass Q-TOF LC/MS.  Preparative HPLC was carried out using a Phenomenex Luna 
10 µm C18 (2) column on a Varian Prostar instrument equipped with a PDA detector. Further 
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purification was carried out using a Phenomenex Kinetex 5 µm C18 column (100 Å, 150 mm 
x 4.60 mm) on a Shimadzu HPLC equipped with an SPD-20A UV-vis detector. NMR spectra 
were obtained using a Bruker 600 MHz spectrometer or a Bruker AvanceIII HD 800 MHz 
spectrometer unless otherwise noted.  
 
2.4.2 Bacterial strains and culture conditions 
For cloning, E. coli DH5α and E. coli Top10 chemically competent maximum 
efficiency cells were used (Invitrogen).  For heterologous expression, E. coli BL21(DE3) 
chemically competent cells (Agilent) were transformed with vectors containing hsv or mbo 
expression constructs (Table S2.3). The hrpL expression construct in the pBAD vector was 
previously described.13 All overnight seed cultures were inoculated with a single colony and 
grown in 5 mL media in 14 mL Falcon culture tubes. Antibiotics were used in these 
concentrations, unless otherwise noted: 10 µg/mL tetracycline, 25 µg/mL chloramphenicol, 50 
µg/mL kanamycin, 50 µg/mL spectinomycin, or 100 µg/mL ampicillin. All cultures for 
metabolomics were grown in 100 mL media with the appropriate antibiotic and 100 µL−2 mL 
of a saturated overnight culture. All E. coli cultures were grown in LB Media (Miller, 
granulated, Fisher) at 37 °C to an OD600 between 0.4 and 0.8. E. coli cultures were induced 
with 0.5 mM IPTG and then were incubated at 16 °C overnight, shaking at 225 rpm. P. syringae 
and P. fluorescens starter cultures were grown overnight in King’s B Media (20 g/L Bacto 
Proteose Peptone #3, 1% glycerol by volume, 1.5 g/L K2HPO4, and 0.734 g/L MgSO4, 
dissolved in water). P. syringae cultures containing the pBAD plasmid were induced with 0.2% 
L-arabinose. All other P. syringae pv. tomato DC3000, P. syringae pv. syringae UMAF0158,14 
and P. fluorescens cultures were not induced. Wildtype P. fluorescens Pf0-1 harboring the hsv-
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pBBR5 vector was grown in the presence of 50 µg/mL ampicillin and 50 µg/mL gentamycin. 
P. fluorescens harboring both hsv-pBBR5 and the T3SS (Pf0-1 +T3SS) was grown with 25 
µg/mL tetracycline and 50 µg/mL gentamycin. After reaching an OD600 of >0.6 in King’s B 
media, P. fluorescens and P. syringae cultures were washed with 100 mM MgCl2 and 
resuspended in minimal media (12.8 g/L Na2HPO4 ● 7 H2O, 3 g/L KH2PO4, 0.5 g/L NaCl, 1 
g/L NH4Cl, 1% glycerol by volume, 0.024 g/L MgSO4, 0.0011 g/L CaCl2, and 0.18 g/L 
mannitol, dissolved in water). Once resuspended in minimal media, these cultures were grown 
at 28 °C overnight and 16 °C for another 24 hours shaking at 225 rpm. 
 
2.4.3 Metabolite extraction for metabolomics 
E. coli, P. syringae, and P. fluorescens cultures (100 mL) were spun down at 3500 x g 
and 4 °C for 10 minutes. Solvent extractions were performed using an equal volume of 
supernatant to chloroform-methanol (2:1:1). The top aqueous layer was separated into a round-
bottom flask and concentrated under vacuum. The dried down material was resuspended and 
transferred to a small glass vial, concentrated under reduced pressure, and stored at −20 °C 
until MS analysis.  
 
2.4.4 Protein expression and purification 
Large-scale cultures for protein purification were grown in 1 L of media containing the 
appropriate antibiotic and 1−5 mL of overnight culture. At an OD600 of 0.5−0.8, a sample of 
0.5 mM IPTG was added to induce protein expression. After 16 hours of protein expression, 
cultures were spun down and resuspended in HEPES lysis buffer (50 mM HEPES, 150 mM 
NaCl, 10% glycerol, pH 7.5). Cells were lysed by sonication at 30% amplitude for 3 minutes 
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(0.5 seconds on and 1.5 seconds off). Cell debris was removed by centrifugation at 17,000 rpm 
for 40 minutes and the supernatant was filtered using a 0.45 µm filter (Corning). Each Hsv 
protein was purified using an AKTA FPLC using a 5 mL HiTrap nickel column (GE) at a flow 
rate of 3.0 mL/min. Wash buffer consisted of 50 mM HEPES, 150 mM NaCl, 25 mM 
imidazole, and 10% glycerol (pH 7.5). Elution buffer was the wash buffer with the addition of 
250 mM imidazole. The wash step lasted for 5 column volumes (CVs). The proteins were 
eluted using a gradient of 0−100% of elution buffer over 10 CVs, and then held at 100% for 5 
CVs. HsvB, HsvC, and MboD were further purified using a HiLoad 16/600 Superdex 200 prep 
grade size exclusion column (GE) on the FPLC using the lysis buffer described above. The 
column was equilibrated with lysis buffer at a flow rate of 0.5 mL/min for 1.5 CVs, then protein 
was loaded onto the column and eluted over 1.5 CVs using the same buffer and flow rate. 
 
2.4.5 Amidinotransferase substrate assay conditions 
To identify the preferred substrates of the amidinotransferase proteins HsvA and 
MboE, L-arginine was incubated with potential substrates that accept the amidino group. Each 
reaction mixture contained two amino acids at 10 mM each (L-Arg and L-Lys, L-Arg and 
spermidine, or L-Arg and spermine). For MboE, L-Cys, Gly, and L-Ala were also tested with 
L-Arg. Each mixture also contained 100 mM HEPES (pH 7.5) and 20 µM purified HsvA to a 
final volume of 50 µL. Samples were incubated at 37 °C for 2 hours. Enzymes were omitted 
in negative controls. A sample of 10 µL was injected onto a Gemini C18 column (Phenomenex) 
on LC-MS and separated with a gradient of 2−73% acetonitrile (0.1% formic acid) over 25 
minutes. This assay showed that HsvA catalyzes the transfer of the amidino group from L-Arg 
to spermidine, spermine, or L-lysine. Based on peak areas, the amidinospermidine product is 
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present at the highest level, suggesting spermidine is the preferred substrate. MboE activity 
could not be reconstituted. 
 
2.4.6 ATP-grasp substrate assay conditions 
A malachite green dye assay (PiColorLock, Innova Biosciences) was used to identify 
the preferred substrates of the ATP-grasp enzymes HsvB and MboC by quantifying free 
phosphate (Pi) release. Activity of MboD and HsvC were not reconstituted using this method. 
Substrate assays were conducted in 100 µL scale in a microcentrifuge tube, and consisted of 
2.0 mM amino acids, 10 µM of each enzyme, 10 mM MgCl2, 5 mM ATP, and 50 mM HEPES 
(pH 7.5). After 30 minutes, reactions were diluted 1 in 10 with DI water into a 96-well plate to 
a final volume of 200 µL, then 50 µL Gold mix reagent and 20 µL stabilizer were added. After 
30 minutes of incubation, UV-vis absorption of the products at 635 nm was measured on a 
Tecan infinite M1000 Pro plate reader. Assays containing L-Phe produced the most Pi, 
indicating that HsvB preferentially activates L-Phe. MboC activity was observed when hArg 
and Ala, hArg and Cys, and Arg and Ala were incubated together. 
 
2.4.7 Characterization of phevamine biosynthetic pathway 
Sequential assays were conducted to elucidate the biosynthesis of phevamine A. Based 
on the structures of pre-phevamine, amidinotransfer by HsvA or condensation with L-Val by 
HsvC may occur as the first step. This rationale led us to examine three potential biosynthetic 
pathways: HsvA → C → B, HsvC → A → B, and HsvC → B → A. An initial assay was 
conducted for either HsvA or HsvC. The HsvA assay consisted of 10 mM L-arginine, 10 mM 
spermidine, 100 mM HEPES (pH 7.5), 20 µM HsvA, and water in a 100 µL volume. Protein 
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was removed after a 30 minute incubation at room temperature using a 3000 Da Amicon Ultra 
filter (Millipore) and the small molecule filtrate was collected. To this assay mixture, we added 
2 mM MgCl2, 1 mM ATP, 2 mM L-valine, and 10 µM HsvC. Protein was again removed after 
30 minutes at room temperature with a 3000 Da filter and an aliquot was collected for LC-MS 
analysis. Finally, 2 mM L-phenylalanine and 10 µM HsvB were added, and the reaction was 
incubated at room temperature for 30 minutes before the reaction was quenched with 
acetonitrile at a ratio of 1:1 for 15 minutes, precipitated protein was removed by centrifugation, 
and the supernatant was analyzed by LC-MS. The initial HsvC assays consisted of 2 mM 
spermidine, 2 mM L-valine, 100 mM HEPES (pH 7.5), 2 mM MgCl2, 1 mM ATP, 10 µM 
HsvC, and water in a 100 µL volume. After 30 minutes at room temperature, HsvC was 
removed with a 3000 Da filter. To one set of assays, 10 mM L-arginine and 20 µM HsvA were 
added. To the other set of assays, 2 mM L-phenylalanine and 10 µM HsvB were added. Both 
sets of reactions were incubated at room temperature for 30 minutes before removing protein 
with a 3000 Da filter. Aliquots were taken for LC-MS analysis. These reactions were then 
incubated with the remaining constituents that had not been added: 2 mM L-phenylalanine and 
10 µM HsvB or 10 mM L-arginine and 20 µM HsvA. Reactions were incubated at room 
temperature for 30 minutes before they were quenched with acetonitrile at a ratio of 1:1 and 
the precipitated protein was removed by centrifugation. All aliquots were diluted 5 folds with 
water for LC-MS analysis. Phevamines were only produced when the reaction order was HsvA 






2.4.8 Preparative scale in vitro enzymatic synthesis of phevamines 
One milliliter one-pot enzymatic assays for phevamine A were conducted at room 
temperature for two hours. Assays contained 5 mM L-arginine, 5 mM spermidine, 1 mM L-
valine, 0.5 mM L-phenylalanine, 100 mM HEPES (pH 7.5), 2 mM MgCl2, 1 mM ATP, 20 µM 
HsvA, 10 µM HsvB, 10 µM HsvC, and water. The reaction was then quenched with 1 mL 
acetonitrile to precipitate protein overnight at −20 °C. The precipitated proteins were removed 
by centrifugation. Phevamines were purified from the supernatant using one round of 
preparative HPLC, and two rounds of analytical HPLC using conditions described in the 
supplementary methods. 
 
2.4.9 Purification of phevamine A 
Assay supernatants were concentrated under reduced pressure and injected onto the 
prep HPLC at a flow rate of 15 mL/min with water and acetonitrile (both containing 0.1% 
trifluoroacetic acid) as mobile phases. The solvent gradient was held at 2% acetonitrile for 10 
minutes, then 5% acetonitrile for 5 minutes, and 10% acetonitrile for 15 minutes, before being 
ramped up to 95% over another 20 minutes. Fractions containing phevamine A (28–30 min 
retention time) were concentrated under reduced pressure and injected onto the analytical 
HPLC using the same mobile phases as those for the prep HPLC. The solvent gradient ramped 
from 2−30% acetonitrile over 35 minutes before ramping up to 95% for another 8 minutes 
(flow rate: 0.5 mL/min). Fractions containing phevamine A were collected at retention times 
of 20−25 minutes, and concentrated. To separate the two regio-isomers, a final round of 
purification was conducted on the analytical HPLC with an extended gradient at 10−20% 
acetonitrile for 25 min. Specifically, the solvent gradient started at 2−5% acetonitrile over 5 
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minutes, then 5−10% over another 5 minutes, and finished with 10−20% for another 25 
minutes (flow rate: 0.5 mL/min). Fractions with retention times between 17.5–19.5 minutes 
were collected and concentrated. LC/MS analysis showed that the concentrated sample 
contained ~95% pure phevamine A (67% yield). 
 
2.4.10 NMR spectroscopy for phevamine A and B 
All spectra for in vitro purified phevamine A and B were obtained using a Bruker 
AvanceIII HD (800 MHz 1H reference frequency, 201 MHz for 13C) equipped with a 5 mm 
CPTCL 1H-13C/15N cryo probe. Non-gradient phase-cycled dqfCOSY spectra were acquired 
using the following parameters: 0.6 s acquisition time, 400−600 complex increments, 8, 16 or 
32 scans per increment. Non-gradient HSQC and HMBC spectra were acquired with these 
parameters: 0.25 s acquisition time, 200−500 complex increments, 8−64 scans per increment. 
1H, 13C-HMBC spectra were optimized for JH,C = 6 Hz. HSQC spectra were acquired without 
decoupling. NMR spectra were processed and baseline corrected using Mestrelabs MNOVA 
software packages. NMR assignments are shown in Tables S2.4 and S2.5. 
 
2.4.11 MS and MS/MS analysis 
Culture extracts, in vitro synthesized phevamines, and chemically synthesized 
phevamine A, were analyzed by Agilent 6520 accurate-mass Q-TOF LC/MS using a 
Phenomenex Kinetex 5 µm C18 column (100 Å, 150 mm x 4.60 mm). Mobile phases were 
water and acetonitrile, each containing 0.1% formic acid. The gradient was held at 2% 
acetonitrile for 2 minutes before ramping up to 45% acetonitrile over 17 minutes at a flow rate 
of 0.4 mL/min. For each phevamine sample, m/z 434.324 was selected at a retention time of 8 
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± 5 minutes and analyzed by MS fragmentation. Targeted MS/MS was conducted using 30 V 
collision energy, 970.9 ms/sec acquisition time, and a 4 m/z isolation width.  
 
2.4.12 Plant material and bacterial growth 
Arabidopsis thaliana was grown in walk-in growth rooms maintained at 21 °C/18 °C 
(day/night) with a 9 hour/15 hour (day/night) cycle. Nicotiana benthamiana was grown in a 
walk-in growth room maintained at 26 °C/22 °C with a 12 hour/12 hour (day/night) cycle and 
a LGM550 professional LED grow light system (LED Grow Master Global). For maintenance 
and transformation, Pseudomonas strains were grown in King's B media (KB) at 28 °C. For 
infiltration or dipping in planta, Pseudomonas strains were grown in liquid culture overnight 
with the appropriate antibiotics, then plated on a petri dish and incubated overnight before 
resuspension in 10 mM MgCl2. 
 
2.4.13 Bacterial growth assay 
Pto, Pto∆hsv, Pto-Cor -, and Pto-Cor -∆hsv cells were resuspended in 10 mM MgCl2 to 
a final concentration of 2 × 105 cfu/mL. Twenty-day-old A. thaliana Col-0 seedlings were 
dipped in bacterial solutions supplemented with Silwet L-77 (Momentive), and growth was 
assessed at day 0 and 3 days post-infection as described by Tornero and Dangl.90 Eight samples 
containing 3 seedlings were collected for each treatment. 
 
2.4.14 Callose deposition measurement 
Three- to five-week-old Arabidopsis plants were infiltrated with Pseudomonas strains 
at an OD600 of 0.2 in 10 mM MgCl2 and collected after about 20 hours. To visualize callose 
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deposition, leaves were stained with aniline blue.91 The tissue was cleared and dehydrated with 
96% ethanol overnight at 37 °C. Cleared leaves were washed with distilled water and then 
stained in 0.01% aniline blue in 150 mM K2HPO4 (pH 9.5) for 4 hours at room temperature. 
Stained samples were washed and mounted in distilled water and examined by epifluorescence 
(LEICA M205 FA) with 100X magnification. Images were taken at the region below the 
infiltrated zone of each leaf. Counting of accumulated callose foci was carried out using ImageJ 
(NIH). For each treatment, 10 to 20 leaves were processed. 
 
2.4.15 Phylogenetic Analysis  
The phylogenetic history of Pseudomonas syringae was inferred by Yang et al.73 
Protein sequences of toxin biosynthetic genes listed in Table S2.1 were used as BLAST queries 
to search for homologous protein sequences in the 292 P. syringae genomes (available as of 
Jan. 2017, PATRIC). A hit with over 80% protein sequence identity was considered positive. 
The tree was visualized using iTOL.92 
 
2.4.16 Metabolite dependence on T3SS 
The hsv operon was cloned into the pBBR5 plasmid containing a constitutive promoter 
and gentamycin resistance marker.93 P. fluorescens Pf0-1 and Pf0-1 + T3SS were both 
transformed with hsv-pBBR5 by electroporation using the method described by Choi and 
Schweizer.94 Cultures (100 mL) were grown and extracted as described above to detect 





2.4.17 Generation of Pseudomonas clean deletion mutants 
Pseudomonas knockout clones were generated using MTN1907, a modified version of 
pLVC-D, which allows for SacB counter-selection.13, 95-96 Overlapping primers MT1881, 
MT1880, MT1877, and MT1878 (Table S2.2) were used to generate a chimeric fragment 
composed of the ~200 bp sequence upstream of hsvA fused to the ~200bp region downstream 
of hsvC. The chimeric fragment was sub-cloned into MTN1907 and Pseudomonas was 
transformed with the plasmid to obtain a merodiploid after recombination. Two merodiploids, 
with a 3’ end and a 5’ end insertion, were selected to generate two independent Pseudomonas 
clones with clean hsv deletion for each parental strain (Pto DC3000, Pto-Cor -, PtoΔhrcC, 
PtoD28E) after growth on media containing 5% sucrose for the second recombination (see Fig. 
S2.29 and S2.30). For complementation, the hsv operon was sub-cloned into pBAV226 
downstream of the NptII promoter and transformed into PtoD28EΔhsv2 (see Fig. S2.30). The 
pBAV226 vector contains the sequence encoding the HA-tag downstream of the gateway 
cassette, but the HA tag was not included in the product of hsvC because the stop codon was 
retained.  
 
2.4.18 ROS burst measurement 
Leaf disks from 4-week-old A. thaliana Col-0, or N. benthamiana were placed into a 
96-well plate with 100 µl of water in each well. Twelve leaf disks were used per treatment. 
After overnight incubation for Arabidopsis leaf disks, or 20 hours for N. benthamiana leaf 
disks, each sample was treated with 100 µl of reaction mix, including 17 mg/mL of luminol 
(Sigma), 10 mg/mL of horseradish peroxidase (HRP; Sigma), distilled water, flg22 at 
concentrations ranging from 5 nM to 100 nM, and L-arginine, and polyamines at concentrations 
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typically ranging from 200 µM to 800 µM. Phevamines and pre-phevamine were used at the 
same concentration as L-arginine (Sigma) or spermidine. Luminescence was measured 
immediately with 0.5 s integration and 1 min interval over 45 min using a SpectraMax L 
(Molecular Devices). For each experiment, 8 to 12 leaf-disks per condition were monitored. 
The flg22 peptide (QRLSTGSRINSAKDDAAGLQIA) was synthesized by Genscript.78 
 
2.4.19 Calcium burst measurement 
Leaf disks of 3- to 4-week-old A. thaliana lines pMAQ2 expressing the apoaequorin 
gene under the control of the cauliflower mosaic virus 35S promoter85 were collected in a 96-
well plate and incubated overnight with 100 µM coelenterazine native (BYOSYNTH).85 
Luminescence was measured as in the ROS burst assay, with the exception that luminol and 
HRP were excluded from the reaction mix. 
 
2.4.20 Synthesis of phevamine A 
General information 
Chemicals were purchased from commercial suppliers and used without further 
purification. Fmoc-derivatized amino acids were purchased from Alfa Aesar.  N1, N4-bis-boc-
spermidine was purchased from Chem-Impex International. Diethylamine and DIPEA were 
purchased from Sigma-Aldrich. N,N′-Di-Boc-1H-pyrazole-1-carboxamidine and 
trifluoroacetic acid were purchased from Acros Organics. HATU was purchased from 
Oakwood Products Inc. NMR solvents were purchased from Cambridge Isotope Laboratories. 
Normal-phase column chromatography was performed on silica gel (230−400 mesh). 
Reversed-phase chromatography was performed on C18-bonded silica, either on Phenomenex 
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Kinetex C18 or Phenomenex Luna C18. High-resolution mass spectra (HRMS) were obtained 
using an Agilent 6520 Q-TOF LC/MS. Proton, carbon and fluorine magnetic resonance spectra 
(1H NMR, 13C NMR, and 19F NMR) were recorded on a Bruker model DRX 400 or 600 (1H 
NMR at 400 MHz or 600 MHz, 13C NMR at 101 MHz or 151 MHz) or on a Bruker AVANCE 
III-OneBay500 (13C NMR at 235 MHz) spectrometer. NMR experiments are reported in δ 
units, parts per million (ppm), and were referenced to CDCl3 (δ 7.26 ppm for 1H and 77.0 ppm 
for 13C), DMSO (2.50 ppm), MeOD (3.31 ppm) or D2O (4.79 ppm) as internal standards. 1H 
NMR data are reported as follows: chemical shift, multiplicity (s = singlet, bs = broad singlet, 
d = doublet, dd = doublet of doublets, t = triplet, td = triplet of doublets, m = multiplet), 




This synthesis followed a similar procedure as Kaur et al.97 1,3-Diaminopropane (3 g, 
40.5 mmol, 1 eq.) was dissolved in a 10% solution of Et3N in MeOH (30 mL); the mixture was 
cooled to 0 °C. In a flame dried flask, di-tert-butyl dicarbonate (4.4 g, 20 mmol, 0.5 eq.) was 
dissolved in MeOH and added to the cooled solution (via addition funnel). The reaction 
mixture, which did not appear homogeneous, was stirred overnight at room temperature (RT). 
The solvent was then removed under reduced pressure. The crude mixture was treated with 
10% Na2CO3 (10 mL, three times) and extracted with CH2Cl2. The combined organic phases 
were dried over anhydrous Na2SO4 and the solvent was removed under reduced pressure. The 
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desired product (1) was obtained as a white solid (1.65 g, 23% yield) and used in the subsequent 
step without further purification.  
1H NMR (400 MHz, CDCl3) δ 1.20 (bs, 1H), 1.44 (s, 9H), 1.64-1.57 (m, 2H), 2.76 (t, J = 6.6 
Hz, 2H), 3.22-3.16 (m, 2H), 4.90 (bs, 1H). 
 
N-(4-(3-Boc-1,3-diaminopropane)butyl)phthalimide (2)  
 
This reaction followed a procedure similar to that used by Wang et al. (2012).98 N-Boc-
1,3-diaminopropane (1.38 g, 7.9 mmol, 1.1 eq.)  was dissolved in MeCN (15 mL) at RT and 
K2CO3 (3.43 g, 24.8 mmol, 5 eq.) was added. N-(4-Bromobutyl)phthalimide (2.2 g, 7.7 mmol, 
1 eq.) was then added and the reaction mixture was heated to 50 °C and stirred at this 
temperature for 18 hours. Subsequently, the mixture was warmed up to RT and treated with 
H2O. The mixture was extracted with EtOAc; the combined organic phases were dried over 
anhydrous Na2SO4 and the solvent was removed under reduced pressure. The desired product 
(2) was obtained (3 g, quantitative yield) and used in the subsequent step without further 
purification. 
1H NMR (400 MHz, CDCl3) δ 1.90−1.82 (m, 2H), 1.40 (bs, 9H), 1.65-1.56 (m, 2H), 1.75−1.69 
(m, 2H), 2.39−2.36 (m, 2H), 3.20-3.13 (m, 4H), 3.71−3.64 (m, 2H), 4.96 (bs, 1H), 7.75−7.72 






N-(4-(N1,N3-bis-Boc-1,3-diaminopropane)butyl)phthalimide (3)  
 
This reaction followed a similar procedure to that was used by Wang et al. (2014).99 
The substrate was dissolved in methanol (40 mL) and di-tert-butyl dicarbonate (1.7 g, 7.8 
mmol, 1 eq.) was added. The reaction mixture was stirred at RT for 12 hours, then the solvent 
was removed under reduced pressure. The Boc-bisprotected product (3) was obtained as a pale, 
yellow oil (3.3 g, 87% yield) and used in the subsequent step without further purification. 
1H NMR (400 MHz, CDCl3) δ 1.45−1.44 (m, 2H), 1.70−1.67 (m, 5H), 1.95−1.85 (m, 1H), 2.42 
(bs, 2H), 3.27−3.10 (m, 4H), 3.76−3.70 (m, 2H), 7.75−7.72 (m, 2H), 7.88−7.84 (m, 2H). 
 
N1, N4-bis-Boc-spermidine (4) 
 
This reaction used a procedure similar to that was used by Wang et al. (2014).99 To a 
solution of tert-butyl (3-((tert-butoxycarbonyl)amino)propyl)(4-(1,3-dioxoisoindolin-2-
yl)butyl)carbamate (3) (780 mg, 1.64 mmol) in EtOH (30 mL), hydrazine hydrate (0.83 mL) 
was added and the reaction mixture was stirred for 12 hours at RT. The solvent was removed 
under reduced pressure and the residue was suspended in 10% ammonia and extracted with 
CHCl3; the combined organic phases were dried on anhydrous Na2SO4 and the solvent was 
removed under reduced pressure. The desired product (4) was obtained as a pale, yellow oil 
(340 mg, 60% yield) and used in the subsequent step without further purification.  
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1H NMR (400 MHz, CDCl3) δ 1.48−1.46 (m. 18H), 1.66−1.57 (m, 7H), 2.43−2.40 (m, 1H), 
2.49−2.46 (m, 1H), 2.74−2.71 (m, 1H), 3.26−3.12 (m, 4H), 3.69 (bs, 1H), 4.90 (bs, 1H), 5.78, 




To a solution of N1, N4-bis-Boc-spermidine (4) (250 mg, 0.724 mmol, 1.0 eq.) in 
CH2Cl2 (20 mL) on ice, Fmoc-Val-OH (295 mg, 8.68 mmol, 1.2 eq.), and DIPEA (252.2 µL, 
1.448 mmol, 2.0 eq.) were added. The reaction was stirred at room temperature for 16 hours. 
The crude reaction mixture was purified by flash chromatography (hexanes/ethyl acetate 
gradient) to afford pure product (5) (310 mg, 64% yield) as a white solid.  
1H NMR (400 MHz, CDCl3) δ 0.97 (m, 6H), 1.46 (s, 9H), 1.47 (s, 9H), 1.52 (m, 2H), 1.66 (m, 
2H), 2.15 (m, 2H), 3.07-3.35 (m, 9H), 4.23 (t, J = 7.0 Hz, 1H), 4.36 (m, 1H) 4.44 (m, 1H), 7.32 






To a solution of Fmoc-(S)-Val-bis-Boc-spermidine (5) (310 mg, 0.465 mmol, 1.0 eq) 
in 20 mL MeCN, diethylamine (500 L, 2.5% v/v) was added. The reaction was stirred at 
room temperature for 2 hours. The crude reaction mixture was concentrated under reduced 
pressure. Ethyl acetate (25 mL) was added, and the reaction mixture was concentrated again. 
The crude reaction mixture was dissolved in CH2Cl2 (20 mL) and added to a mixture of Fmoc-
Phe-OH (216 mg, 0.558 mmol, 1.2 eq.), HATU (269 mg, 0.6975 mmol, 1.5 eq.), and DIPEA 
(162 µL, 0.742 mmol, 2.0 eq.) previously kept under stirring for 20 minutes on ice. The 
reaction was stirred at room temperature for 16 hours. The crude reaction mixture was purified 
by flash chromatography (hexanes/ethyl acetate gradient) to afford pure product (6) (190 mg, 
50% yield) as a white solid. 
 1H NMR (400 MHz, CDCl3) δ 0.87 (d, J = 6.8 Hz, 3H), 0.92 (d, J = 6.8 Hz, 3H), 1.47 (s, 18H), 
1.51 (m, 2H), 1.69 (m, 2H), 2.19 (m, 2H), 3.05−3.35 (m, 11H), 4.19 (t, 1H), 4.31 (m, 1H), 4.41 
(m, 1H), 4.51 (m, 1H), 7.20 (m, 2H), 7.31 (m, 5H), 7.41 (t, J = 7.4 Hz, 2H), 7.54 (d, J = 7.6 




A solution of Fmoc-(S)-Phe-(S)-Val-bis-Boc-spermidine (6) (60 mg, 0.072 mmol) in 
CH2Cl2 (2 mL) was cooled to 0 °C and 800 μL of trifluoroacetic acid was added dropwise. The 
reaction was stirred at room temperature for 3 hours. The crude reaction mixture was 
concentrated under reduced pressure. Toluene was added, and the sample was concentrated 
under reduced pressure until dry. The pure product (7) (23 mg, 32% yield over two steps) was 
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obtained as a white solid: 1H NMR (400 MHz, MeOD) δ 0.96 (m, 6H), 1.59 (m, 2H), 1.70 (m, 
2H), 2.07 (m, 3H), 3.00−3.27 (m, 10H), 4.08 (d, J = 7.2 Hz, 1H), 4.16 (t, J = 7.0 Hz, 1H), 4.26 
(m, 1H), 4.34 (m, 1H), 4.42 (m, 1H), 7.16 (m, 1H), 7.21−7.32 (m, 5H), 7.40 (t, J = 7.6 Hz, 
2H), 7.58 (d, J = 7.6 Hz, 2H), 7.81 (d, J = 7.6 Hz, 2H); HRMS (EI) m/z [M + H]+ Calculated 




To a solution of Fmoc-(S)-Phe-(S)-Val-spermidine (7) in DMF (2 mL), which has been 
cooled to 0 °C, DIPEA (200 µL) and N,N′-Di-Boc-1H-pyrazole-1-carboxamidine (24 mg, 
0.072 mmol, 1.0 eq.) were added. The reaction was stirred for 4 hours at room temperature. 
The crude reaction mixture was purified directly using reverse-phase prep HPLC (Phenomenex 
Luna C18, H2O/MeCN gradient) and then purified using a second round of reverse-phase 
HPLC (Phenomenex Kinetex C18, H2O/MeCN gradient). The product (8) was purified as a 
white solid (23 mg, 37% yield over 2 steps). 1H NMR (600 MHz, MeOD) δ 0.96 (m, 6H), 1.49 
(s, 9H), 1.55 (s, 9H), 1.60 (m, 2H), 1.72 (m, 2H), 1.95 (m, 2H), 2.07 (m, 1H), 3.02 (m, 4H), 
3.14−3.23 (m, 2H), 3.24-3.35 (m, 2H) 3.47 (m, 2H), 4.08 (d, J = 7.2 Hz, 1H), 4.17 (t, J = 7.5 
Hz, 1H), 4.26 (m, 1H), 4.35 (m, 1H), 4.42 (m, 2H), 7.23 (m, 2H), 7.30 (m, 5H), 7.40 (m, 2H), 
7.58 (t, J = 6.9 Hz, 2H), 7.81 (d, J = 7.8 Hz, 2H); HRMS (EI) m/z [M + H]+ Calculated for 
C47H66N7O8 856.497, observed 856.499. 
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Phevamine A (9) 
 
To a solution of Fmoc-(S)-Phe-(S)-Val-spermidine-N,N’-Di-Boc-1H-guanidine (8) (23 
mg, 0.027 mmol) in 2.5 mL of MeCN, diethylamine (300µL) was added. The reaction was 
stirred for 6 hours at room temperature. The crude reaction mixture was concentrated under 
reduced pressure. Ethyl acetate was added, and the reaction mixture was concentrated again. 
The reaction mixture was dissolved in CH2Cl2 (3 mL) on ice and trifluoroacetic acid (350 µL) 
was added dropwise. The reaction was stirred at room temperature for 12 hours. The reaction 
mixture was concentrated under reduced pressure. Toluene was added and the reaction mixture 
was concentrated until dryness. The reaction mixture was purified by reverse-phase HPLC 
(Phenomenex Kinetex C18, H2O/MeCN gradient). The final product phevamine A (9) was 
obtained as a white solid (9.8mg, 67% yield). 1H NMR (400 MHz, D2O) δ 0.79 (d, J = 6.8 Hz, 
3H), 0.82 (d J = 6.8 Hz, 3H), 1.49 (m, 2H), 1.60 (m, 2H), 1.84 (m, 1H), 1.87 (m, 2H), 2.97−3.20 
(m, 8H), 3.20 (t, J = 6.8 Hz, 2H), 3.87 (d, J = 8.4 Hz, 1H), 4.22 (t, J = 7.2 Hz, 1H), 7.15 (m, 
2H), 7.29 (m, 3H); HRMS (EI) m/z [M + H]+ Calculated for C22H40N7O2 434.324, observed 






2.4.21 Ornithine acetyl transferase inhibition by mangotoxin 
 Plant ornithine acetyl transferase (OAT) was obtained from 72 g of Arabidopsis 
thaliana leaves. A. thaliana leaves were frozen with liquid nitrogen and crushed using a mortar 
and pestle until a fine powder was obtained. Leaves were then soaked for 1 hour in 200 mL 
plant extraction buffer consisting of 50 mM Tris base (pH 7.5), 0.2 mM cobalt chloride, 1 mM 
reduced glutathione, and 0.1 mM phenylmethylsulfonyl fluoride. The resulting mixture was 
filtered using a Buchner funnel filter and was stored –20 °C until use. 
 The full OAT assay consisted of 1.2 mM N-acetyl-L-Orn, 1.2 mM L-Glu, 50 µL plant 
extract containing OAT, and 25 µL of extract from 100 mL of UMAF culture. The following 
controls were conducted: no bacterial extract, no plant extract, no N-acetyl-L-Orn, no L-Glu, 
full assay with the extract of Pto extract instead of UMAF, and a control without plant extract 
but with Pto extract instead of UMAF. Assays were incubated at 37 °C for one hour, then 
quenched with 250 µL of 0.4 M citric acid and boiled at 95 °C for 90 seconds. After quenching, 
reactions were analyzed by LC-MS. 
 
2.4.22 E. coli growth inhibition by P. syringae pv. syringae UMAF0158 
 E. coli growth inhibition assays were conducted using PMS agar plates using E. coli 
BL21 as the indicator strain in the top agar. The PMS media consisted of ammonium phosphate 
monobasic (1 g/L; pH 7), potassium chloride (0.2 g/L), magnesium sulfate (0.2 g/L), dextrose 
(2 g/L), and agar (1.2% w/v). Top agar contained 0.1% E. coli BL21 by volume. Some plates 
also contained L-ornithine in the top agar (30 mM). Each plate was divided into four quadrants, 
and 5 µL of water or King’s B media was added to two quadrants as negative controls. Varying 
amounts (2-10 µL) of either UMAF or Pto overnight seed culture were added to the remaining 
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quadrants. Each plate was duplicated, one containing Orn in the top agar and one without Orn 
for reversion of E. coli growth inhibition by UMAF by Orn supplementation. Plates were 
incubated at room temperature for one day, then at 37 °C for a second day. 
 
2.4.23 ATP-grasp sequence similarity network formation 
 Amino acid sequences of specified ATP-grasp enzymes were obtained from NCBI. 
Sequences were uploaded as FASTA files to the Enzyme Function Initiative-Enzyme 
Similarity Tool (EFI-EST) web-tool with an E-value of 10-100 unless otherwise specified.100 
When indicated, all other ATP-grasp enzymes were included by specifying the ATP-grasp 
Pfam value: IPR011761. Sequences were limited to only those 150-700 AA in length. 
Networks with nodes depicting proteins with ≥50% sequence identity were visualized in 







CHAPTER 3: TOWARD IDENTIFYING A SMALL MOLECULE PRODUCED BY A 
CONSERVED GENE CLUSTER FROM A HYPERVIRULENT KIWIFRUIT 
PATHOGEN 
 
3.1 INTRODUCTION  
 Bacterial plant pathogens produce a wide range of small molecules. Small molecules, 
such as siderophores, phytotoxins, and antibiotics, play key roles in the fitness of the producing 
pathogens in the presence of plants and other microbes. Pseudomonas syringae infects a wide 
range of plants and consists of more than 50 pathovars defined based on the plant infected. 
Therefore, it is widely used as a model to study virulence, the ability to infect plants. P. 
syringae produces several well-known toxins: tabtoxin, coronatine, phaseolotoxin, and 
syringomycin, some of which inhibit plant or microbial enzymes at nanomolar 
concentrations.39, 103 Recently, our group used a genome-guided approach to identify a new 
small molecule, phevamine A, which promotes the virulence of P. syringae pv. tomato 
DC3000 by suppressing plant immunity.12  
P. syringae pv. actinidiae (Psa) is a pathogenic bacterium that leads to virulence in 
kiwifruit, having a devastating impact on the agriculture and economy (estimated loss of $310-
410 million in the next five years and $885 million in the next 15 years in New Zealand 
alone).104 Outbreaks of this bacterial strain also affect Japan, Italy, and Korea, becoming a 
global problem.72 Therefore, it is essential to understand the molecular mechanisms of 
infection so methods to overcome and prevent infection can be devised. Here, we focus on an 
uncharacterized biosynthetic gene cluster conserved in many hypervirulent Psa strains and set 
out to identify the functions of the enzymes encoded in this gene cluster. 
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The gene cluster (denoted hereafter as kwf) was identified by large-scale genome 
sequencing and bioinformatics analysis.72 This gene cluster was present in many virulent 
strains but not present in low-virulent strains, suggesting this cluster may be involved in 
virulence. The kwf cluster encodes two nonribosomal peptide synthetases (NRPSs), which 
form peptide bonds independently of the ribosome and are a major enzyme family for the 
biosynthesis of small molecules.105 The functions of enzymes encoded by this cluster are 
uncharacterized. We propose that the kwf-encoded enzymes synthesize bioactive small 
molecules and focus on the cluster from Psa NZV-13.  
NRPS genes are modular and each module consists of domains, the minimum usually 
being a condensation domain (C), an adenylation domain (A), and a thiolation domain (T).106 
The T domain contains a free thiol formed by transfer of 4’-phosphopantetheine from 
coenzyme A to an active site serine and this thiol covalently binds acyl reaction 
intermediates.106 The phosphopantetheine arm is a long, flexible linkage that facilitates 
interaction with other NRPS domains.106 The A domain confers substrate specificity and 
activates a single amino acid by adenylation, releasing pyrophosphate (PPi).106 The C domain 
then catalyzes the formation of amide bonds between amino acids loaded on the T domains.106 
Other domains commonly found in NRPSs include a reductase (R) domain, which can reduce 
the final product from a carboxylic acid to an alcohol or aldehyde,106 and a methyltransferase 
(MT) domain may also be present, which facilitates transfer of a methyl group from S-
adenosyl-L-methionine.106  
This chapter discusses the efforts to identify the small molecule produced by kwf-
encoded enzymes. Concurrent with structure elucidation of the small molecule, the kwf-
encoded enzymes are investigated to understand the chemistry involved in biosynthesis. The 
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workflow that has been set up for the hsv operon is applied to the kwf cluster, in which 
metabolomics and enzymology are combined to piece together the structure of the bioactive 
small molecule. Here, we present preliminary results from in vitro enzymology and 
metabolomics for the kwf cluster in Psa NZV-13. Two substrates were identified for NRPS 
enzymes. Metabolomics experiments have been conducted in two different systems, P. 
syringae and E. coli. Results from these experiments are complementary and will aid the 
identification and structural elucidation of the final small molecule. 
 
3.2 RESULTS 
3.2.1 In vitro enzyme reconstitution of the kwf cluster. 
Enzymology was used as a starting point for characterization of the metabolite(s) 
produced by the kwf gene cluster from Psa NZV-13 (Figure 3.1). Identification of preferred 
substrates for some enzymes encoded by the cluster can facilitate the identification of the small 
molecule product(s) by metabolomics. The two NRPS proteins OrfB and OrfE likely build the 
peptide backbone of the small molecule, and therefore were the initial focus of in vitro 
reconstitution. OrfB and OrfE contain a total of three A domains (Table 3.1), thus we propose 
that these enzymes activate and condense three amino acids.  
 
 




Table 3.1. Bioinformatic analysis of the kwf cluster. 
Protein Predicted function(s) 
OrfT Standalone T-domain 
OrfA Luciferase-like monooxygenase 
OrfB NRPS (C-A-MT-T-R) 
OrfC MFS transporter 
OrfD MbtH-like protein 
OrfE NRPS (C-A-T-C-A-T) 
OrfF Small LanB 
OrfG Aminotransferase 
OrfH 4-hydroxyphenylpyruvate dioxygenase 
OrfI α-hydroxy-acid oxidase 




Various constructs were generated for each NRPS module. The constructs examined 
include full length OrfB, full length OrfE, OrfB A-MT-T, OrfB A, OrfE1 A-T-C, OrfE2 A-T, 
OrfE1 A, and OrfE2 A. Substrate specificity of each A domain was examined using an ATP-
32PPi exchange assay. Briefly, this assay involves incubating the A domain-containing enzyme 
with a potential amino acid substrate, the cofactors ATP and Mg2+, and an excess of radioactive 
32PPi (“hot”) and regular PPi (“cold”). If the A domain activates the amino acid present by 
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adenylation, the reverse reaction incorporates radioactive 32PPi into 32ATP (Scheme 3.1). 
Labeled 32ATP is then trapped by activated charcoal, resuspended in a scintillation cocktail, 
and counted using a scintillation counter. As a general rule of thumb, we used greater than 9% 
substrate conversion or 30 times of the counts from a no-substrate control as a threshold to 
consider the adenylating activity as significant.  
 
Scheme 3.1. Reaction scheme for ATP-32PPi exchange assays. The NRPS A domain confers 
specificity for a specific amino acid. This amino acid is then acylated by ATP, releasing 
pyrophosphate (PPi) and forming an aminoacyl bond with AMP. This amino acid can then be 
loaded onto the T domain, forming a thioester linkage. Radioactive 32PPi can be added to the 
A domain reaction, and the reverse reaction will incorporate 32P into ATP, which can be 
adsorbed to activated charcoal and the radioactivity can be measured by scintillation counting. 
 
NRPS constructs were first tested with amino acid substrates that had been predicted 
by NRPS prediction online software.107-108 OrfB is predicted to activate hydroxyphenylglycine, 
which is likely synthesized by the OrfH, OrfI, and OrfJ proteins encoded by the kwf cluster. 
These three proteins are homologous to HmaS, Hmo, and HpgT, respectively, which 
synthesize hydroxyphenylglycine (hpg) in Amycolatopsis orientalis (48-50% sequence 
identity) and incorporate it into the natural product chloroeremomycin.109 In contrast to this 
prediction, none of the OrfB constructs activated D- or L-hpg under our assay conditions, but 
instead, OrfB A activated L-Phe with a 40% overall conversion (Fig. 3.2). Further, the MbtH 
protein OrfD was necessary for this activity; in the absence of OrfD, the activity observed is 
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0.8% of that of the reaction in the presence of OrfD (Fig. 3.2). The first module of OrfE, OrfE1 
A-T-C, was predicted to activate L-Ser, and we found it was able to activate both L-Ser and L-
Ala with 47% and 41% conversion, respectively (Fig. 3.3). We were unable to reconstitute the 
activity for the second OrfE module, in which the 10 amino acid code of the A domain only 
has weak bioinformatic prediction, such as L-His, L-Glu, or β-Ala. All 20 proteinogenic amino 
acids (excluding Trp) and β-Ala were tested, but no activation was observed (Fig. 3.4). Other 
tailoring enzymes are also present in the kwf cluster with putative functions assigned through 
bioinformatics analyses, but these enzymes have not been the focus of current in vitro 
enzymatic assays (Table 3.1, Fig. 3.1). 
 
 
Figure 3.2. OrfB prefers to activate l-Phe based on results from ATP-32PPi exchange 





Figure 3.3. OrfE1 prefers to activate l-Ser and l-Ala based on results from ATP-32PPi 
exchange assays. The A domain of the first OrfE module activates both L-Ser and L-Ala. 
 
Figure 3.4. OrfE2 does not prefer any canonical amino acids based on results from ATP-
32PPi exchange assays. The A domain of the second OrfE module does not activate any of the 
19 proteinogenic amino acids tested or β-Ala. 
 
3.2.2 Metabolomics analysis of Psa NZV-13 and cloning and heterologous expression of the 
kwf cluster in E. coli. 
NRPS deletion mutants of orfB and orfE were generated by Paul Rainey’s group in 
New Zealand, including single deletion mutants of each gene and a double deletion mutant. 
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Each strain was grown in triplicate alongside wildtype NZV-13 and all culture supernatants 
were extracted with chloroform-methanol. Cultures were grown in both M9 minimal media 
and KB rich media. Both solvent layers were dried down and analyzed by LC-HRMS, and the 
metabolomic profiling data was uploaded to XCMS. Features were sorted by fold change. 
Several mass-to-charge ratios (m/z) have been identified that are significantly more abundant 
in wildtype extracts than any of the knockout extracts. We expect the product of the kwf cluster 
to contain a tripeptide backbone synthesized by the NRPS enzymes, and therefore we expect 
the mass of the product to range from 400-700 Da, so we looked for masses in that range to 
identify the final small molecule product as well as below that range to identify intermediates. 
Some mass features were identified that fit the above criteria and have the following m/z values 
(and fold changes between wildtype and double mutant): 254.1388 (20,557), 324.1376 (5,966), 
320.1348 (5,917), 508.2406 (3,754), and 336.1232 (3,244).  
Metabolomics experiments were also conducted using a heterologous expression 
system. The entire 22.5 kb kwf cluster was cloned into the pETcoco-1 plasmid using Gibson 
assembly, then E. coli Bap1 was transformed with either the full construct or empty pETcoco-
1 (Fig. 3.5). Since orfB, orfA, and orfT (BAT) face the opposite way of the rest of the cluster 
(Fig. 3.1), BAT was cloned after orfK with its own T7 promoter to ensure all genes would be 
transcribed. Therefore, a T7 promoter was present in the plasmid before orfC that promotes 
transcription through orfK, and then a second T7 promoter was present before orfB to promote 
transcription through orfT (Fig. 3.5). This construct was expressed in E. coli and compared to 
empty pETcoco-1 using the same technique as above for Psa NVZ-13 and knockout strains. 
Again, mass features with m/z values in the 400–700 range were selected. Molecules with the 
highest fold changes were the following: 719.2382 (233 fold change), 604.2273 (139), 
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443.1278 (118), 436.1342 (72), 626.2217 (58), 452.1177 (55), 606.2371 (51), 699.3995 (32), 
and 720.3989 (18). Two molecules were identified in both P. syringae and E. coli 
metabolomics with high fold changes and the m/z values of these molecules were 231.1714 
and 137.0479. The masses of these molecules are smaller than expected, suggesting the 
molecules are biosynthetic intermediates or shunt products due to overexpression of the kwf 
cluster in E. coli. 
 
Figure 3.5. Schematic of the kwf cluster cloned in pETcoco-1. The entire construct is 35 kb 
and contains a T7 promoter before orfC and another before orfB. 
3.2.3 Antibacterial activity testing of small molecules isolated from Psa NZV-13. 
 
Psa NZV-13 was found to produce a small molecule with a mass-to-charge ratio of 


















postdoc in the group, Wenlong Cai (Fig. 3.6). Stereochemistry has not yet been characterized. 
Purified compound was provided by Dr. Cai and antibacterial assays were conducted using the 
agar diffusion method. No activity was observed against any strain tested as a target. 
Subsequently, whole cell culture of the wildtype strain was used for antibacterial assays. 
Again, no activity was observed against any strain tested. The KB-1 purified compound and 
whole cell NZV-13 culture were tested against the following strains: P. syringae pv. syringae 
UMAF0158, P. syringae pv. syringae B728a, P. syringae pv. tomato DC3000, P. syringae pv. 
pisi, P. syringae Cit7, P. fluorescens Pf0-1, P. fluorescens Pf0-5, P. putida S12, P. putida F1, 
P. aeruginosa PA14, E. coli MG1655, Micrococcus luteus, Enterococcus faecalis, and 
Bacillus subtilis BSU168. Select representative strains tested against KB-1 are shown in Figure 
S3.1. KB-1 was also tested against the fungus Rhizoctonia solani, but no inhibition was 
observed against fungal growth. 
 
Figure 3.6. Chemical structure of KB-1. KB-1 was isolated from Psa NZV-13 culture and 
the structure was assigned by Wenlong Cai using one- and two-dimensional NMRs. 








3.3.1 In vitro enzyme reconstitution of the kwf cluster. 
OrfB was found to selectively activate L-Phe and the first module of OrfE was found 
to activate L-Ser. OrfB activity was only observed when the MbtH protein OrfD was present, 
but the activity of OrfE1 did not require OrfD. MbtH proteins are thought to act as chaperone 
proteins to bind to an A domain and induce enzyme activity of the A domain.110-111 OrfB was 
predicted to activate hpg. This prediction was further supported by the homology between 
OrfH, OrfI, and OrfJ and the hpg biosynthetic enzymes. However, our results suggest that OrfB 
activates L-Phe instead of hpg. The homologs to hpg enzymes in the kwf cluster may catalyze 
similar chemistry to hpg biosynthesis but synthesize phenylglycine. Another interesting 
observation is that only certain NRPS constructs yielded activity for ATP-32PPi exchange 
assays. The OrfB-A-MT-T construct didn’t activate L-Phe, but OrfB-A did. Similarly, OrfE1-
A-T-C activated L-Ser and L-Ala, but OrfE1-C-A-T and OrfE1-A did not activate any amino 
acids. This observation indicates it is necessary to generate several constructs for each NRPS 
module to identify a properly folded and active construct. To determine whether L-Ser or L-
Ala is the native substrate for OrfE1, kinetics experiments will be performed to obtain 
Michaelis-Menten parameters. If the measured kcat and KM exist in a range relevant under 
physiological conditions, the amino acid is likely the native substrate. Lastly, since no activity 
was observed for OrfE2-A, OrfE2-C-A-T, or OrfE2-A-T, this enzyme might activate a 
noncanonical substrate, or these constructs may not be active.  
Identification of substrates accepted by other kwf-encoded enzymes and the chemistry 
these enzymes catalyze will help piece together the small molecule product. Due to the lack of 
any thioesterase NRPS domain, which could cyclize the peptide product, the amino acid 
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substrates will most likely be linked together as a linear peptide and not a cyclic peptide. An 
N-methyltransferase domain is also present in OrfB, which likely methylates the nitrogen of 
phenylalanine. OrfF is a putative small LanB (sLanB) enzyme, which contains only one of the 
two domains in LanB enzymes. LanB enzymes glutamylate an amino acid, typically serine or 
threonine, and then eliminate the glutamate to form dehydroalanine or dehydrobutyrine 112. 
Small LanB enzymes only possess the first domain, so they likely catalyze glutamylation of an 
amino acid sidechain but not dehydration. OrfG shares sequence homology with pyridoxal 
phosphate-dependent aminotransferases that catalyze the conversion between an alpha-keto 
acid and an amino acid. OrfC is annotated as a membrane transport protein, potentially 
transporting the small molecule out of (or into) a cell. The remaining protein is OrfA, which 
shares 48% sequence identity with luciferase-like monooxygenases, so it could be 
incorporating oxygen into the final product via hydroxylation, epoxidation, or Baeyer-Villiger 
oxidation.113 OrfB contains a C-terminal reductase domain, suggesting that the NRPS product 
is released as an aldehyde or an alcohol, and OrfB contains the termination module. Thus, the 
action of OrfE likely precedes that of OrfB. OrfE contains an N-terminal C domain, which 
likely acts as a starter C domain that links a lipid or another moiety to the N-terminus of the 
molecule. Reconstitution of the activities of these enzymes requires knowledge of their 
potential substrates and will be accelerated once the small molecule produced by the kwf cluster 
is identified. 
 
3.3.2 Metabolomics analysis of Psa NZV-13 and cloning and heterologous expression of the 
kwf cluster in E. coli. 
 We expect the product of the kwf cluster to be a tri- or tetrapeptide due to the following 
rationale. The NRPS enzymes contain a total of three A domains which can activate three 
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amino acid substrates, but there are three condensation domains to link these, so there may be 
three amide bonds and therefore four amino acids. Interestingly, there is a standalone T domain 
upstream of orfA, but no corresponding A domain, so it is unclear what substrate may be 
tethered there natively. Further, OrfF, the sLanB enzyme, may be glutamylating the compound 
and therefore adding one more amino acid. Therefore, the expected product mass could range 
anywhere from ~400-700 Da. From enzymatic data, we expect the compound to contain a 
serine and a phenylalanine/phenylglycine (pg) due to OrfE1 and OrfB activity, respectively. 
OrfE2 may be activating a noncanonical residue and OrfF may be adding a glutamate residue 
to the molecule. Several potential structures were proposed based on these stipulations as a 
starting point. Further modifications were then also taken into account including the 
aminotransferase OrfG, the methyltransferase domain of OrfB, and the putative 
monooxygenase OrfA. From aforementioned P. syringae metabolomics data, the metabolite 
with an m/z of 324.1376 could correspond to the Phe-Ser-Ala tripeptide, and the metabolite 
with an m/z of 336.1232 could correspond to pg-Ser-Pro. However, these structures are likely 
to be intermediates of the kwf pathway and none of the other hypothesized structures match 
with the metabolite features (m/z) identified from XCMS analysis. Further in vitro studies will 
need to be conducted before metabolomics data can be analyzed further. 
 
3.3.3 Antibacterial activity of Psa NZV-13 culture and isolated natural product. 
 Neither the compound KB-1 nor the wildtype Psa NZV-13 possess antibacterial 
activity against any strain tested. Bacillus subtilis is a representative Gram-positive strain of 
bacteria and the E. coli strain tested is a representative Gram-negative strain. Further, the E. 
coli strain used has a weakened cell membrane (imp), making it more susceptible to 
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antibacterial compounds, indicating that NZV-13 is not a potent antibiotic against E. coli. 
Several other species and strains of Pseudomonas were tested as well since pseudomonads are 
soil bacteria and interactions and competition among different pseudomonads likely occur in 
the soil. However, no antibacterial activity was observed against the pseudomonads tested. 
Similarly, activity was not observed against the representative Enterococcus or Micrococcus 
strains, both of which are Gram-positive bacteria. Therefore, it seems that NZV-13 does not 
produce antibiotics under the laboratory conditions tested, at least not in high enough quantities 
to be detected in agar diffusion assays. Other growth conditions will need to be tested to further 
explore the antimicrobial activities of Psa NZV-13.  
 
3.4 CONCLUSION AND OUTLOOK 
Several experiments are currently underway to characterize the product of the kwf 
cluster and its biosynthesis. The following enzyme constructs have been cloned, expressed, 
and are ready to be purified for in vitro enzyme assays: OrfT, OrfA, and OrfG. Purified protein 
has already been obtained for OrfF, OrfH, OrfI, and OrfJ. Both hydroxyphenylpyruvate and 
phenylpyruvate will be incubated with OrfH, OrfI, and OrfJ consecutively to synthesize hpg 
or pg, respectively. Other purified constructs of OrfB will be tested for the methyltransfer 
reaction catalyzed by the MT domain and reduction to an alcohol or aldehyde catalyzed by the 
reductase domain. OrfB has already been purified as the full C-A-MT-T-R construct and as A-
MT-T for these experiments. Isotope-enriched L-Phe will also be used for metabolomics 
experiments, based on in vitro activation data by OrfB, which can help narrow down the data 
output from XCMS. OrfE2 A will be tested with noncanonical NRPS substrates while other 
OrfE2 constructs are generated and purified for testing. Once in vitro experiments and 
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metabolomics experiments suggest a common mass, the molecule will be purified for 
subsequent structure elucidation by tandem MS and NMR. Once the natural product 
synthesized by the kwf cluster is purified and characterized, it will be subjected to biological 
assays with plants to characterize its mechanism of action. 
 In this project, the same approach was used as the phevamine A project with the goal 
of connecting uncharacterized biosynthetic gene clusters to bioactive small molecules. The 
dual approach combining metabolomics with in vitro enzymology can be widely applied to 
identify natural products based on biosynthetic gene clusters. These studies will likely yield 
new natural product structures and biosynthetic reactions. The natural products we identify 
from phytopathogens will likely advance the understanding of the virulence of these pathogens 
and pave the way for overcoming bacterial virulence to treat crops against various infectious 
diseases. 
 
3.5 EXPERIMENTAL PROCEDURES 
3.5.1 General 
All chemicals were purchased from Sigma-Aldrich or Fisher. Primers were ordered 
from Eton Bioscience (Table S3.1). Polymerase, restriction enzymes, and ligase were 
purchased from New England Biolabs. DNA manipulation kits were purchased from Qiagen, 
Zymo, and Thermo Scientific. PCR reactions were carried out using an Eppendorf Nexus 
GSX1 thermocycler with Q5 DNA polymerase. General genetic manipulation of E. coli was 
carried out using standard protocols.89 LC-MS analysis was conducted using an Agilent 6520 




3.5.2 Bacterial strains and culture conditions 
For cloning, E. coli Top10 chemically competent maximum efficiency cells were used 
(Invitrogen).  For heterologous expression, E. coli Bap1 or E. coli BL21(DE3) 
electrocompetent cells (Agilent) were transformed with vectors containing expression 
constructs. BAP1 was used instead of BL21 for constructs containing a full NRPS gene. All 
constructs are listed in Table S3.2.  
All overnight seed cultures were inoculated with a single colony and grown in 5 mL 
media in 14 mL Falcon culture tubes. Antibiotics were used in the following concentrations 
unless otherwise noted: 25 µg/mL chloramphenicol, 50 µg/mL kanamycin, or 100 µg/mL 
ampicillin. All cultures for metabolomics were grown in 100 mL media with the appropriate 
antibiotic and 100 µL−2 mL of a saturated overnight culture. All E. coli cultures were grown 
in LB Media (Miller, granulated, Fisher) at 37 °C to an OD600 between 0.4 and 0.8. E. coli 
cultures were induced with 0.5 mM IPTG and then were incubated at 16 °C overnight, shaking 
at 225 rpm. P. syringae cultures were grown overnight in King’s B Media (20 g/L Bacto 
Proteose Peptone #3, 1% glycerol by volume, 1.5 g/L K2HPO4, and 0.734 g/L MgSO4, 
dissolved in water). When specified, some P. syringae cultures were resuspended in M9 once 
reaching an OD600 of >0.6 in King’s B media. In this case, P. syringae cultures were washed 
with 100 mM MgCl2 and resuspended in M9 minimal media (12.8 g/L Na2HPO4 ● 7 H2O, 3 
g/L KH2PO4, 0.5 g/L NaCl, 1 g/L NH4Cl, 1% glycerol by volume, 0.024 g/L MgSO4, 0.0011 
g/L CaCl2, and 0.18 g/L mannitol, dissolved in water). P. syringae cultures were grown at 28 
°C overnight and 16 °C for another 24 hours while shaking at 225 rpm and were not induced. 
When P. syringae was supplemented with phevamine A, the molecule was added once the cells 
were resuspended in minimal media to a final concentration of 5 µM. When spent media was 
 
80 
added to E. coli heterologous expression cultures, a 2-day-old 100 mL Psa NZV-13 culture 
was gently pelleted and 10 mL supernatant was added to 90 mL LB containing 
chloramphenicol and 1 mL E. coli harboring the kwf cluster or empty pETcoco-1 vector 
control. These cultures were grown at 37 °C and induced as usual. 
 
3.5.3 Gibson assembly of the kwf cluster 
 orfBAT was first cloned into pET30a and then amplified for Gibson to incorporate a T7 
promoter into the fragment. pETcoco-1 was digested with HindIII-HF (NEB) and blunt ends 
were generated using mung bean nuclease (NEB) to prevent plasmid recircularization. Three 
fragments (CDE, FGHIJK, and T7-BAT) were amplified by PCR and assembled before adding 
the digested pETcoco-1 backbone to ensure BAT didn’t anneal to the T7 promoter on the 
plasmid. Each fragment was added in equal amounts (300 ng each) with 2X HiFi DNA 
Assembly Mix (NEB) to a total volume of 26 µL. The reaction was incubated 50 °C for 20 
min, then 600 ng of digested pETcoco-1 was added with an equal volume of additional 2X 
HiFi DNA Assembly Mix and the reaction was incubated at 50 °C for another 1 hour.  
 
3.5.4 Metabolite extraction for metabolomics 
E. coli and P. syringae cells were removed by centrifugation of the cell culture (100 
mL) at 3500 x g and 4 °C for 10 minutes. Solvent extractions of the culture supernatant were 
performed using an equal volume of supernatant to chloroform-methanol (2:1:1). The top 
aqueous layer was separated into a round-bottom flask and concentrated under vacuum. The 
dried down material was resuspended and transferred to a small glass vial, concentrated under 
reduced pressure, and stored at −20 °C until MS analysis.  
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3.5.5 Protein expression and purification 
Large-scale cultures for protein purification were grown in 1 L of media containing the 
appropriate antibiotic and 1−5 mL of overnight culture. At an OD600 of 0.5−0.8, a sample of 
0.5 mM IPTG was added to induce protein expression. After 16 hours of protein expression, 
cell pellets were collected by centrifugation and resuspended in phosphate lysis buffer (50 mM 
K2HPO4, 150 mM NaCl, 10% glycerol, pH 8.1). Cells were lysed by sonication at 30% 
amplitude for 3 minutes (0.5 seconds on and 1.5 seconds off). Cell debris was removed by 
centrifugation at 17,000 rpm for 40 minutes and the supernatant was filtered using a 0.45 µm 
filter (Corning). Each Orf protein (excluding OrfD) was purified using an AKTA FPLC using 
a 5 mL HiTrap nickel column (GE) at a flow rate of 3.0 mL/min. Wash buffer consisted of 50 
mM K2HPO4, 150 mM NaCl, 25 mM imidazole, and 10% glycerol (pH 8.1). Elution buffer 
was the wash buffer with the addition of 250 mM imidazole. Tagless OrfD was purified using 
a 5 mL HiTrap Q HP anion exchange column (GE) at a flow rate of 3.0 mL/min. Wash buffer 
consisted of 20 mM TRIS (pH 8.0). Elution buffer consisted of 20 mM TRIS (pH 8.0) and 1 
M NaCl. The wash step lasted for 5 column volumes (CVs). All proteins were eluted using a 
gradient of 0−100% of elution buffer over 10 CVs, and then held at 100% for 5 CVs. All Orf 
proteins were further purified using a HiLoad 16/600 Superdex 200 prep grade size exclusion 
column (GE) on the FPLC using the lysis buffer described above. The column was pre-
equilibrated with lysis buffer at a flow rate of 0.5 mL/min for 1.5 CVs, then protein was loaded 






3.5.6 MS and MS/MS analysis 
Culture extracts and in vitro reactions were separated on a Phenomenex Kinetex 5 µm 
C18 column (100 Å, 150 mm x 4.60 mm) and analyzed using Agilent 6520 accurate-mass Q-
TOF LC/MS. Mobile phases were water and acetonitrile, each containing 0.1% formic acid. 
The flow rate was 0.4 mL/min. The gradient was held at 2% acetonitrile for 5 minutes before 
ramping to 20% acetonitrile over 10 minutes, then to 65% over 5 minutes, then 95% over 10 
minutes, and held at 95% for 5 minutes. 
 
3.5.7 Agar diffusion bacterial growth inhibition assays  
 Bacterial growth inhibition assays were conducted on M9 or LB agar plates. LB media 
consisted of tryptone (10 g/L), sodium chloride (10 g/L), yeast extract (5 g/L), and agar (1.2% 
w/v). M9 media consisted of sodium phosphate dibasic heptahydrate (12.8 g/L), potassium 
phosphate monobasic (3 g/L), sodium chloride (0.5 g/L), ammonium chloride (1 g/L), glycerol 
(1% v/v), magnesium sulfate (0.024 g/L), calcium chloride (0.0011 g/L), mannitol (0.18 g/L), 
and agar (1.2% w/v). An overnight seed culture of each bacterium tested was diluted 1:1000 
with water and a sample of 100 µL was plated and allowed to dry. One filter paper disc was 
placed into each quadrant of a plate. One quadrant contained a water negative control and KB-
1 was added in three varying concentrations on each plate. Alternatively, a sample of 10 µL of 
Psa NZV-13 overnight seed culture was added to two quadrants and compared to two 
ΔorfBΔorfE quadrants. Plates were incubated at 28 °C for 24 hours, or 24 hours at 37 °C for 







CHAPTER 4: ISOLATION OF PEPTICINNAMIN E AND CHARACTERIZATION 




 Natural products have important applications in improving human health and treating 
disease. For example, many natural products and derivatives exhibit potent antitumor 
activities, and have been and are continuing to be explored in cancer therapy. Pepticinnamins 
are a class of natural products that inhibit protein farnesyltransferase (PFT).114 Approximately 
30–40% of all human tumors, and more than 80% of major tumors from colon, breast, and 
pancreatic cancer, contain mutations in genes encoding Ras proteins.114-115 Tumor-associated 
Ras requires S-farnesylation of its C-terminus for function in promotion of transduction of 
growth signals, which ultimately leads to cell proliferation and malignancy,114-116 thus the 
enzymes responsible for Ras farnesylation, the PFTs, are promising anticancer targets.  
Pepticinnamins were first isolated from the actinomycete Streptomyces sp. OH-
4652.117 Six pepticinnamin variants have been characterized, denoted pepticinnamin A-F, and 
are all potent inhibitors of PFT. The most potent in this class is pepticinnamin C with an IC50 
of 100 nM, and the least potent is pepticinnamin D with an IC50 of 1 µM.118 Literature studies 
focus on pepticinnamin E, the most abundant pepticinnamin produced by Streptomyces by ten-
fold, which has an IC50 of 300 nM.118 The six pepticinnamins have been separated by HPLC 
and m/z values are reported for all, but only pepticinnamin E has been structurally characterized 
(Fig. 4.1).114-115, 117-119 The producing strain Streptomyces sp. OH-4652 has not been sequenced 





Figure 4.1. Structure of pepticinnamin E. Bonds and atoms highlighted in red show the two 
tyrosine residues likely encoded by the NRPS Pcm2. 
 
In this chapter, we report the first isolation and purification of pepticinnamin E from 
Actinobacteria bacterium OK006. We also identify the gene cluster responsible for production 
of the pepticinnamins, which contains two nonribosomal peptide synthetases and several other 
tailoring enzymes. Bioinformatic analysis and preliminary biochemical characterization 
suggest that the nonribosomal peptide synthetase (NRPS) Pcm2 likely activates and condenses 
two L-tyrosine residues with the assistance of the MbtH protein Pcm3. Finally, we propose that 
the putative hydroxylase enzyme Pcm11 catalyzes hydroxylation of L-tyrosine using a 
biopterin cofactor, while L-tyrosine is bound to the NRPS T domain. 
 
4.2 RESULTS 
4.2.1 Isolation of pepticinnamin E 
The gene cluster encoding the pepticinnamins was identified by Kevin Santa Maria in 
the group through bioinformatic analyses (Fig. 4.2, Table 4.1). He searched in sequence 
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genome databases for biosynthetic gene clusters that encode a potential halogenase along with 
enzymes that could synthesize the diketopiperazine moiety and cinnamoyl tail. The genome of 
the Actinobacteria bacterium OK006 strain was identified, harboring a candidate gene cluster 
for pepticinnamin biosynthesis. The strain was acquired and initial metabolomics analysis 
showed production of a compound with the same m/z as pepticinnamin E. An insertional 
mutant of the NRPS gene pcm2 in the cluster was generated by Andy Chan in the group, and 
metabolomics analysis showed that pcm2 deletion abolished production of pepticinnamin E. 
This result, along with bioinformatic analysis of the gene cluster, confirmed that the pcm gene 
cluster is responsible for pepticinnamin production. 
 
 
Figure 4.2. Gene cluster responsible for pepticinnamin production. Genes in red are 
relevant to this study. 
 
Table 4.1. Predicted protein functions of select pepticinnamin enzymes.  
Protein Predicted Function 
Pcm1 Halogenase 
Pcm2 NRPS (C-A-T-C-A-MT-T) 
Pcm3 MbtH-like protein 
Pcm10 Methyltransferase 




To confirm the structure of pepticinnamin isolated from A. bacterium OK006, and to 
obtain materials for biological studies, we cultured the bacterium in large scale. Several liters 
of A. bacterium OK006 culture were grown. Cells were collected from the culture by gentle 
centrifugation and the cell pellets were extracted with methanol. Extracts were washed with 
water then with hexanes to remove polar and nonpolar impurities, respectively. Crude extracts 
were then purified by three rounds of reverse-phase preparative HPLC and then two rounds of 
reverse-phase analytical HPLC. Each round of purification was analyzed by LC-MS to confirm 
the presence pepticinnamin E. A major challenge is that in each round of purification several 
peaks are present that exhibit the same m/z of 908 as pepticinnamin E, which suggests structural 
isomers of pepticinnamin E are also present. The most abundant compound with the correct 
m/z value is the one pursued for further purification and structural analysis. On average, 
extractions yielded approximately 0.4 mg of pepticinnamin E per liter of culture. After 5 
rounds of purification, proton NMR of the purified molecule identified most of the expected 
proton shifts for pepticinnamin E, supporting that the compound isolated from A. bacterium 
OK006 is identical to pepticinnamin E. The spectrum also contained several proton peaks we 
cannot account for, suggesting that some impurities are still present (Fig. 4.3, Table S4.3). 
Unfortunately, further purification of the material led to the loss of pepticinnamin. Further 





Figure 4.3. 1H NMR (600 MHz) of pepticinnamin E. Spectrum acquired in MeOD. 
Integrated peaks correspond to signals expected for pepticinnamin E. DMSO and acetone 
contaminants are labeled on the spectrum, water and methanol signals are highlighted in red at 
the top. 
 
4.2.2 Expression and characterization of Pcm NRPSs and accessory proteins 
The NRPS Pcm2 contains two modules with the domain architecture C-A-T-C-A-MT-
T. Several truncations, along with full-length protein, were designed, cloned, expressed, and 
purified. Each construct was inspected for its ability to activate tyrosine and similar substrates 
by ATP-32PPi exchange assays. We expect the A domains in both modules to activate tyrosine 




Several assay conditions and components were tested to optimize enzyme activity. 
Activity of Pcm2.1 was tested at both pH 8 and pH 9, and Pcm2.1 appears to exhibit slightly 
more activity at the higher pH (Fig 4.4). However, the activity was very low, only 2–3 folds 
above the background signal. We obtained soluble proteins for full length Pcm2 coexpressed 
with the MbtH Pcm3. However, since we expect both modules to activate tyrosine, then if 
activity were to be observed by ATP-32PPi exchange assays, then the activity could not be 
attributed to the responsible Pcm2 module. Therefore, each module of Pcm2 was individually 
cloned, expressed, and purified, including Pcm2.1 (C-A-T) and Pcm2.2 (C-A-MT-T). Pcm2.1 
was coexpressed with Pcm3, but Pcm2.2 was not. Interestingly, Pcm2.1 was significantly more 
soluble than Pcm2.2, even though Pcm2.2 was expressed with an MBP tag to improve 
solubility. Both purified Pcm2.1 and Pcm2.2 have been tested for activity with the following 
substrates: L-Ala, L-Cys, L-Glu, L-Lys, L-Thr, L-Phe, L-Trp, L-Tyr, D-Tyr, and L-DOPA (Fig. 
4.5, Fig. 4.6). Both modules were tested in the presence of purified Pcm3 in vitro, but no 
enzyme activity was observed for any substrate tested. Subsequently, both individual A 
domains were cloned and expressed, and the activities of these domains will be examined by 





Figure 4.4. ATP-32PPi exchange results for Pcm2.1 activity as a function of pH. Pcm2.1 
appears to be slightly more active at pH 9 than pH 8. 
 
 
Figure 4.5. ATP-32PPi exchange results for Pcm2.1. Pcm2.1 activated both L-Phe and L-Tyr 
at very low levels (0.7% conversion each). D-Tyr and L-DOPA assays were run in a separate 
experiment, as indicated by the red line, therefore direct comparisons between these substrates 




Figure 4.6. ATP-32PPi exchange results for Pcm2.2. Pcm2.2 did not activate any of the 
substrates tested. D-Tyr and L-DOPA assays were run in a separate experiment, as indicated by 
the red line, therefore direct comparisons between these substrates cannot be made. Percent 
conversion for D-Tyr as a substrate is 0.1%. 
 
4.2.3 Characterization of the tyrosine hydroxylase Pcm11 
One tailoring enzyme encoded by the pcm gene cluster is the putative tyrosine 
hydroxylase, Pcm11. Interestingly, this enzyme is homologous to tyrosine hydroxylases in 
mammals and human parasites that convert L-Tyr to L-DOPA using a biopterin cofactor, but 
these enzymes are rare in bacteria.120-121 One of the few bacterial examples includes the 
phenylalanine hydroxylase PacX from Streptomyces coeruleoribudus.122 We hypothesize that 
Pcm11 catalyzes hydroxylation of tyrosine in the meta position. Kevin Santa Maria showed 
that the methyltransferase Pcm10 methylates 3,4-dihydroxy-L-phenylalanine (DOPA) but not 
L-Tyr, suggesting that the hydroxylation by Pcm11 occurs prior to methylation by Pcm10. 
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Timing of hydroxylation in relation to chlorination at the 2-position remains to be 
characterized. 
Preliminary results showed that Pcm11 did not modify D- nor L-tyrosine in the 
presence of tetrahydrobiopterin (BH4) or (±)-6-Methyl-5,6,7,8-tetrahydropterine (6MPH4). 
Catalase was also present in reactions to break down peroxide byproducts of the biopterins to 
prevent non-enzymatic oxidation.123 Different reaction conditions were explored to optimize 
enzyme activity including several reaction buffers, pH values, incubation times and 
temperatures, but still no hydroxylation was observed. 
 
4.3 DISCUSSION 
4.3.1 Isolation of pepticinnamin E 
 The low yields of pepticinnamin E from the extraction and purification may be due to 
several factors, including limited availability of tyrosine or phenylalanine precursors in the 
cell, loss of materials during 5 rounds of purification, and stability of the compound. 
Pepticinnamin E appears to be unstable and degrade within a few days, because it was no 
longer detected when stored either at room temperature or −20 °C, and as a dried powder or 
resuspended in methanol. Finally, several isomers of pepticinnamin E appeared to be present, 
which have not been reported. Each HPLC fraction containing pepticinnamin E had several 
peaks, all containing the same 908 mass, and no other reported pepticinnamin molecules have 






4.3.2 Expression and characterization of Pcm NRPSs and accessory proteins 
 There are several possible reasons why neither Pcm2 module is able to activate any of 
the amino acids tested within our acceptable threshold (9-30% conversion). First, perhaps the 
presence of the MbtH protein is hindering enzyme activity. It’s possible that coexpression with 
Pcm3 is necessary, which is why Pcm2.1 is much more soluble and abundant than Pcm2.2, but 
maybe Pcm3 is inducing a conformational change in the Pcm2 modules, rendering them 
inactive. Secondly, perhaps the modules are not active as designed. The A domains have been 
cloned and will be purified to test in this assay to overcome this possibility. Lastly, the 
substrates tested may not be the proper native substrates for either Pcm2 module. Since L-Phe 
and L-Tyr have the same percent conversion with Pcm2.1, perhaps the native substrate is large 
and aromatic, but non-canonical. Similarly, since Pcm2.2 only showed very slight activity 
(0.1%) for D-Tyr, Pcm2.2 may be activating a similar D-amino acid or any other non-canonical 
substrate. It’s very possible that one of these modules requires either O-methylated tyrosine, 
chlorinated tyrosine, or the doubly modified substrate before activation by the NRPS. 
 
4.3.3 Characterization of the tyrosine hydroxylase Pcm11 
 The lack of Pcm11 activity could be due to several different reaction conditions. One 
possibility is that Pcm11 acts on T domain-bound tyrosine instead of free tyrosine in solution. 
Alternatively, the substrate may first be modified by the halogenase Pcm1. Another possibility 
is the lack of a suitable biopterin cofactor. Mammalian tyrosine hydroxylases require BH4 and 





4.4 CONCLUSION AND OUTLOOK 
We identified a new bacterial producer of pepticinnamin E and the gene cluster 
responsible for synthesizing this natural product. We have attempted to reconstitute the activity 
of the NRPS Pcm2 and the tyrosine hydroxylase Pcm11 under many different conditions. 
Although neither enzyme has exhibited significant activity under the conditions tested, our 
efforts have eliminated several reaction conditions and set the stage for future reconstitution.  
To obtain pure pepticinnamin E for full NMR analysis and biological studies, we will 
need to prevent compound degradation by reducing the time necessary for isolation from A. 
bacterium OK006 cultures and purification. The methods optimized for pepticinnamin E will 
be applied to isolate and characterize the other pepticinnamin variants. 
 Several experiments are ongoing to characterize the enzymes in the pepticinnamin 
cluster. Other proteinogenic amino acids will be assayed as substrates for Pcm2 A domains 
with or without the MbtH protein Pcm3. The putative chlorinase Pcm1 will be purified and 
assayed for in vitro activity with tyrosine, which will inform the timing of the modifications. 
The T domains of Pcm2 are currently being expressed and purified for T domain loading assays 
with tyrosine or derivatives. This T domain-loaded substrate will be tested as the substrate for 
the hydroxylase Pcm11. The insights we gain will provide a significant step towards 
elucidating the biosynthesis of pepticinnamin E. Understanding the biosynthesis of this 
molecule will allow for engineered biosynthesis and development of new molecules with 






4.5 EXPERIMENTAL PROCEDURES 
4.5.1 General 
All chemicals were purchased from Sigma-Aldrich or Fisher. Primers were ordered 
from Integrated DNA Technology (Table S4.1). Polymerase, restriction enzymes, and ligase 
were purchased from New England Biolabs. DNA manipulation kits were purchased from 
Qiagen and Thermo Scientific. PCR reactions were carried out using an Eppendorf Nexus 
GSX1 thermocycler with Q5 DNA polymerase. General genetic manipulation of E. coli was 
carried out using standard protocols.89 LC-MS data was obtained using an Agilent 6520 
accurate-mass Q-TOF LC-MS. Compound purification by preparative HPLC was conducted 
using a Varian Prostar instrument equipped with a PDA detector and compounds are separated 
on a Phenomenex Luna 10 µm C18 (2) column. Further rounds of purification was carried out 
using a Shimadzu HPLC equipped with an SPD-20A UV-vis detector and compounds are 
separated on a Phenomenex Kinetex 5 µm C18 column (100 Å, 150 mm x 4.60 mm). NMR 
spectra were obtained using a Bruker 600 MHz spectrometer or a Bruker AvanceIII HD 800 
MHz spectrometer unless otherwise noted.  
 
4.5.2 Bacterial strains and culture conditions 
For cloning, E. coli DH5α and E. coli Top10 chemically competent maximum 
efficiency cells were used (Invitrogen).  For heterologous expression, E. coli BL21(DE3) 
(Agilent) or E. coli BAP1 electrocompetent cells (made in-house) were transformed with 
vectors containing expression constructs (Table S4.2). All overnight seed cultures were 
inoculated with a single colony and grown in 5 mL media in 14-mL Falcon culture tubes. 
Antibiotics were used in the following concentrations, unless otherwise noted: 10 µg/mL 
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tetracycline, 25 µg/mL chloramphenicol, 50 µg/mL kanamycin, 50 µg/mL spectinomycin, or 
100 µg/mL ampicillin. All E. coli cultures for protein expression were grown in LB Media 
(Miller, granulated, Fisher) at 37 °C to an OD600 between 0.4 and 0.8. E. coli cultures were 
induced with 0.5 mM IPTG and then were incubated at 16 °C overnight, while shaking at 225 
rpm. Actinobacteria bacterium OK006 seed cultures using spore stocks were grown in tryptic 
soy broth media (17 g/L tryptone, 3 g/L soytone, 2.5 g/L glucose, 5 g/L sodium chloride, and 
2.5 g/L potassium phosphate dibasic). Large-scale cultures of OK006 for metabolite extraction 
were grown in PPM2 media (10 g/L dextrose, 5 g/L L-asparagine, 0.1 g/L magnesium sulfate 
anhydrous, 0.5 g/L potassium phosphate dibasic, 0.02 g/L iron (II) sulfate heptahydrate, and 
5.85 g/L sodium chloride) at 28 °C with shaking at 225 rpm for 5 days and were not induced. 
 
4.5.3 Protein expression and purification 
Large-scale cultures for protein purification were grown in 1 L of media containing the 
appropriate antibiotic and 1−5 mL of overnight culture. At an OD600 of 0.5−0.8, a sample of 
0.5 mM IPTG was added to induce protein expression. After 16 hours of protein expression, 
cell pellets were collected by centrifugation and resuspended in TRIS or phosphate lysis buffer 
(50 mM TRIS or potassium phosphate dibasic, 200 mM NaCl, 10% glycerol, pH 8). Cells were 
lysed by sonication at 30% amplitude for 3 minutes (0.5 seconds on and 1.5 seconds off). Cell 
debris was removed by centrifugation at 17,000 rpm for 40 minutes and the supernatant was 
filtered using a 0.45 µm filter (Corning). Each Pcm protein, excluding Pcm3, was purified 
using an AKTA FPLC using a 5 mL HiTrap nickel column (GE) at a flow rate of 3.0 mL/min. 
Pcm3 was purified using a 5 mL HiTrap Q anion exchange column (GE). Wash buffer 
consisted of 50 mM TRIS or potassium phoshate, 200 mM NaCl, 25 mM imidazole, and 10% 
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glycerol (pH 8). Elution buffer was the wash buffer containing 250 mM imidazole. A different 
buffer system was used to purify Pcm3: wash buffer consisted of 20 mM TRIS (pH 8) and 
elution buffer consisted of 20 mM TRIS (pH 8) and 1 M NaCl. The wash step lasted for 5 
column volumes (CVs). The proteins were eluted using a gradient of 0−100% of elution buffer 
over 10 CVs, and then held at 100% for 5 CVs. All proteins were further purified using a 
HiLoad 16/600 Superdex 200 prep grade size exclusion column (GE) on the FPLC using the 
lysis buffer described above. The column was first equilibrated with lysis buffer at a flow rate 
of 0.5 mL/min for 1.5 CVs, then protein was loaded onto the column and eluted over 1.5 CVs 
using the same buffer and flow rate. 
 
4.5.4 Metabolite extraction from A. bacterium OK006 
A. bacterium cultures (100 mL) were spun down at 3500 x g and 4 °C for 10 minutes. 
Metabolite extractions from cell pellet were performed using 2 mL methanol per 100 mL 
culture. Pellets were resuspended in methanol for cell lysis and metabolite extraction, vortexed 
vigorously and incubated for 2 hours while shaking at room temperature. Cell debris was 
removed by centrifugation at 3500 x g and 4 °C for 20 minutes. The methanol extract was 
filtered (0.2 µm filter, Corning) into a round bottom flask and concentrated under vacuum. The 
dried down material was resuspended and transferred to a small glass vial, concentrated under 
reduced pressure, and stored at −20 °C until ready for MS analysis or purification. Before 
purification, solvent-solvent extractions were performed. Dry extracts were resuspended in 
ethyl acetate then water was added. The ethyl acetate layer was collected and concentrated 
under reduced pressure. Extracts were then resuspended in methanol and hexanes were added. 
The methanol layer was collected and concentrated under reduced pressure.  
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4.5.5 Purification of pepticinnamin E 
Extracts were resuspended in 5 mL methanol and injected onto the prep HPLC at a 
flow rate of 15 mL/min with water and acetonitrile (both containing 0.1% trifluoroacetic acid) 
as mobile phases. The solvent gradient was held at 2% acetonitrile for 5 minutes, ramped up 
to 58% acetonitrile over 20 minutes and to 95% over another 10 minutes. Fractions containing 
pepticinnamin E (32–33 min retention time) were concentrated under reduced pressure, 
resuspended in 3 mL methanol, and injected onto the prep HPLC a second time. A 2−40% 
acetonitrile solvent gradient over 5 minutes was used, then the gradient was ramped from 40% 
to 60% over 30 minutes. Fractions containing pepticinnamin E (33.5–34.5 min retention time) 
were concentrated under reduced pressure, resuspended in 3 mL methanol, and injected onto 
the prep HPLC a third time. A 2–50% acetonitrile solvent gradient over 5 minutes was used, 
then the gradient was ramped from 50% to 55% over 10 minutes, then from 55% to 60% over 
20 minutes. Fractions containing pepticinnamin E (23–24 min retention time) were 
concentrated under reduced pressure, resuspended in 200 µL methanol, and injected onto the 
analytical HPLC using the same mobile phases. At a flow rate of 0.5 mL/min, the gradient 
ramped from 2% to 45% acetonitrile over 7 minutes, then from 40% to 60% over 30 minutes. 
The fraction containing pepticinnamin E (22–23 min retention time) was concentrated under 
reduced pressure, resuspended in 200 µL methanol, and injected onto the analytical HPLC for 
one final purification. The solvent gradient was ramped from 2% to 45% over 4 minutes, then 
from 45% to 50% over 5 minutes, then from 50% to 55% over 15 minutes. Pepticinnamin E 
was detected in the fraction with a retention time of 18.6–19.6 minutes. LC-MS analysis 




4.5.6 NMR spectroscopy for pepticinnamin E 
Pepticinnamin 1H spectra were acquired using a Bruker AvanceIII HD (600 MHz) 
instrument equipped with a cryo probe. NMR spectra were processed and baseline corrected 
using Mestrelabs MNOVA software packages. NMR assignments are shown in Table S4.3. 
 
4.5.7 ATP-32PPi exchange assays to determine NRPS substrate specificity 
 Assays contained 50 mM TRIS (pH 9), 2 mM magnesium chloride, 1 mM ATP, 4 mM 
amino acid being tested, 4 mM “cold” sodium pyrophosphate, 10 mM “hot/cold” sodium 
pyrophosphate, 4 µM NRPS enzyme, and 5 µM the MbtH protein Pcm3. Assays were diluted 
with water to a final volume of 100 µL. Reactions were incubated at 37 °C for 45 minutes, 
then quenched with a solution containing 1.6% activated charcoal, 3.5% perchloric acid, and 
0.1 M sodium pyrophosphate. NRPS enzymes tested include full Pcm2, Pcm2 module 1 
(Pcm2.1), Pcm2 module 2 (Pcm2.2), and Pcm2.1 A. For each substrate, a no enzyme control 
and a no MbtH control was included, and a no substrate control was also run. Reactions 
contained approximately 120,000 cpm 32PPi each. 
 
4.5.8 Pcm11 tyrosine hydroxylase assay 
 Assays consisted of 100 mM sodium phosphate (pH 6.8), 2 mM DTT, 2.5 mM tyrosine, 
0.5 mM biopterin in either 0.005 M HCl or water, 100 µM iron (II) ammonium sulfate, 10 µM 
Pcm11, and 100 units catalase. Reactions were brought to 100 µL with water. Assays were 
incubated for 40 minutes at room temperature, quenched with 10% TCA for 10 minutes, 




4.5.9 MS analysis 
Pcm11 in vitro enzyme assays were analyzed by an Agilent 6520 accurate-mass Q-
TOF LC/MS using a Phenomenex Kinetex 5 µm C18 column (100 Å, 150 mm x 4.60 mm). 
Mobile phases were water and acetonitrile, each containing 0.1% formic acid. The gradient 
was held at 2% acetonitrile for 5 minutes before ramping up to 45% acetonitrile over 4 minutes 





APPENDIX: SUPPLEMENTAL TABLES AND FIGURES 
Supplemental Tables 
Table S2.1. Gene names and protein identifiers of the biosynthetic operons responsible 











































mboA   
mboB   
mboC   
mboD   
mboE   
Coronatine 
hhd   
ocs   
acsl   
Cfa6   
Cfa7   
ccc   
mcah   
LuxRNew   
CmaA   





Table S2.2. Primers used for cloning of the hsv and mbo operons, cloning of individual 
hsv and mbo genes in E. coli, and generation of hsv knockouts. Nucleotides added for 
cloning are shown in bold. Restriction sites are underlined. 
 




















(HindIII site underlined) 
hsvA_pRSF_sense GACAACAGGGATCCGATGTCATATCAAAAAGCAGAA
C 
(BamHI site underlined) 
 
hsvA_pRSF_anti GACAACAGAAGCTTTCAAATATAACGGTGCAGTCCT 




(SacI site underlined) 
 
hsvB_pACYC_anti GACAACAGAAGCTTTCACTCCTCAAACGGAGGG 

























































CT (BamHI site underlined) 
mboC_pCDF_anti GACAACAGAAGCTT 
TCATACGATTCCAACCTCTGTGTG (HindIII site 
underlined) 
mboD_pACYC_sense GACAACAGGGATCCGATGAAGCATGTCCTGATCATC
AACCGC (BamHI site underlined) 
mboD_pACYC_anti GACAACAGAAGCTTTCAGGTTGCGCGAATAGACGTC
TG (HindIII site underlined) 
mboE_pRSF_sense GACAACAGGGATCCGATGAAAGTGCTCCTGCAGCTT 
(BamHI site underlined) 
mboE_pRSF_anti GACAACAGAAGCTT 










GAGT (NotI site underlined) 
mboDEF_pRSF_sense GACAACAGGGATCCGATGAAGCATGTCCTGATCATC
AACCGC (BamHI site underlined) 
mboDEF_pRSF_anti GACAACAGAAGCTTTCAGGCCTCGCTGGGAGTCTT 
(HindIII site underlined) 
mboB_pRSF_sense GACAACAGGGATCCGATGGCAATCTACAGTGTTCGT
ATT (BamHI site underlined) 
mboB_pRSF_anti GACAACAGAAGCTTCTATCCAAAACTTTCAAGTTCAC




Table S2.3. List of plasmids and strains used in the hsv and mbo studies. 
Insert Plasmid Host strain Source 




E. coli BL21 This study 
hsvC pCDF-duet (Sm) E. coli BL21 This study 
















P. syringae pv. 
tomato DC3000 
13 
hrpL pBAD (Tet) 
P. syringae pv. 
tomato DC3000 
13 
Tn5::cfa6 (DC3118)  
P. syringae pv. 
tomato DC3000 
124-125 
mboB pRSF-duet (Kan) E. coli BL21 This study 




E. coli BL21 This study 




E. coli BL21 This study 
mboDEF pRSF-duet (Kan) E. coli BL21 This study 
  







Table S2.4. 1H (800 MHz) and 13C (200 MHz) NMR spectroscopic data for phevamine A 
in D2O. Chemical shifts were referenced to δ(CH3CO2H) = 2.08 ppm and δ(13CH3CO2H) = 
21.03. 13C chemical shifts were determined via HMBC and HSQC experiments. 1H, 1H-J-
coupling constants were determined from the acquired 1H or dqfCOSY spectra. HMBC 
correlations are from the indicated proton(s) to the indicated 13C atom. 
 
Position δc Proton δH(JHH[Hz]) HMBC 
1 128.49 1-H 7.41(J1,2 = 6.9) 3 
2 129.61 2-H 7.42(J2,1 = 6.9) (J2,3 = 7.1) 2,4 
3 129.86 3-H 7.26(J3,2 = 7.1) 1,3,5 
4 134.07    
5 37.38 5-Ha 3.19(J5a,5b = 14.4) (J5a,6 = 7.5) 3,4,6,7 
  5-Hb 3.23(J5b,5a = 14.4) (J5b,6 = 6.6) 3,4,6,7 
6 54.65 6-H 4.33(J6,5a = 7.5) (J6,5b = 6.6) 4,7 
7 169.28     
8 60.45 8-H 3.98(J8,9 = 8.5)  7,9,10,11,1
2 
9 30.71 9-H 1.95(J9,8 = 8.5) (J9,10 = 6.8) (J9,11 = 6.8) 8,10,11 
10 18.49 10-3H 0.93(J10,9 = 6.8) 8,9,11 
11 18.75 11-3H 0.90(J11,9 = 6.8) 8,9,10 
12 172.58    
13 39.18 13-Ha 3.15(J13a,13b = 13.3) (J13a,14 = 7.0) 12,14,15 
  13-Hb 3.29(J13b,13a = 13.3) (J13b,14 = 7.0) 12,14,15 
14 26.02 14-2H 1.61(J14,13a = 7.0) (J14,13b = 7.0) (J14,15 = 7.6) 13,15,16 
15 23.65 15-2H 1.73(J15,14 = 7.6) (J15,16 = 7.6) 13,14,16 
16 47.74 16-2H 3.10(J16,15 = 7.6) 14,15,17 
17 45.29 17-2H 3.12(J17,18 = 8.0) 16,18,19 
18 25.47 18-2H 2.00(J18,17 = 8.0) (J18,19 = 6.7) 17,19 
19 38.71 19-2H 3.31(J19,18 = 6.7) 17,18,20 






Table S2.5. 1H (800 MHz) and 13C (200 MHz) NMR spectroscopic data for phevamine B 
in D2O. Chemical shifts were referenced to δ(CH3OH) = 3.34 ppm and δ(13CH3OH) = 49.50. 
13C chemical shifts were determined via HMBC and HSQC experiments. 1H, 1H-J-coupling 
constants were determined from the acquired 1H or dqfCOSY spectra. HMBC correlations are 
from the indicated proton(s) to the indicated 13C atom. 
 
Position δc Proton δH(JHH[Hz]) HMBC 
1 128.62 1-H 7.35(J1,2 = 7.0) 3 
2 129.78 2-2H 7.38(J2,1 = 7.0) (J2,3 = 7.1) 2,4 
3 129.99 3-2H 7.23(J3,2 = 7.1) 1,3,5 
4 134.05    
5 37.37 5-2H 3.18(J5,6 = 7.0) 3,6,7 
6 54.66 6-H 4.25(J6,5 = 7.0) 4,7 
7 169.12     
8 55.56 8-H 4.64(J8,9a = 8.7) (J8,9b = 7.0)  7,9,13 
9 37.93 9-Ha 2.99(J9a,9b = 13.2) (J9a,8 = 8.7) 10,11 
  9-Hb 3.04(J9b,9a = 13.2) (J9b,8 = 7.0) 10,11 
10 136.40    
11 129.78 11-2H 7.20(J11,12 = 7.5) 9,11,13 
12 129.35 12-2H 7.34(J12,11 = 7.5) (J12,13 = 7.0) 10,12 
13 127.84 13-H 7.30(J13,12 = 7.0)  11 
14 172.18    
15 60.39 15-H 3.85(J15,16 = 8.4) 14,16,18,1
9 
16 30.81 16-H 1.91(J16,15 = 8.4) (J16,17 = 6.8) (J16,18 = 6.8) 18 
17 18.87 17-3H 0.87(J17,16 = 6.8) 15,16,18 
18 18.72 18-3H 0.91(J18,16 = 6.8) 15,16,17 
19 172.85    
20 39.20 20-Ha 3.08(J20a,20b = 13.5) (J20a,21 = 7.0) 19,21,22 
  20-Hb 3.18(J20b,20a = 13.5) (J20b,21 = 7.0) 19,21,22 
21 26.07 21-2H 1.54(J21,20a = 7.0) (J21,20b = 7.0) (J21,22 = 7.0) 20,23 
22 23.69 22-2H 1.67(J22,21 = 7.0) (J22,23 = 7.8)  20,23 
23 47.80 23-2H 3.05(J23,22 = 7.8) 21,22,24 
24 45.35 24-2H 3.09(J24,25 = 7.8) 23,25,26 
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25 25.56 25-2H 1.98(J25,24 = 7.8) (J25,26 = 7.0) 24,26 
26 38.80 26-2H 3.28(J26,25 = 7.0) 24,25,27 





Table S3.1. Primers used for cloning of the kwf cluster and individual kwf genes in E. coli. 
Nucleotides added for cloning are shown in bold. Restriction sites are underlined.  
Name Sequences (5’ to 3’) 
orfBAT_pET30a_sense GACAACAGCATATGGGTATCGGTTCAAAAACCA
ATTCAAAT (NdeI site underlined) 
orfBAT_pET30a_anti GACAACAGGCGGCCGCTCAGGCTGTTAGGTACT






















ACGTTGTCATC (NcoI site underlined) 
orfD-tagless_pRSF_anti GATACAAAGCTTTTACAGCCCCCCGACCGACAG 
(HindIII site underlined) 
 
orfF_pET30a_sense GACAACAGGGTACCATGGAAAACTCCAAAAGTT
GGCGT (KpnI site underlined) 
orfF_pET30a_anti GACAACAGAAGCTTTCATTTGATCGGATAGTTA
TCAACCCAG (HindIII site underlined) 
orfT_pRSF_sense GATACAGGATCCGATGACCATCGAGATCCAAAC
TCTGGAAGAC (BamHI site underlined) 
orfT_pRSF_anti GATACAGCGGCCGCTCAGGCTGTTAGGTACTGC




GA (KpnI site underlined) 
orfE1-ATC_pRSF_anti GACAACAGAAGCTTTCAAGCGGCTTCCGACAGA
GCC (HindIII site underlined) 
orfE2-A_pRSF_sense GATACAGGATCCGATGCTTCTGGTGTCGCCACC
GGTT (BamHI site underlined) 
orfE2-A_pRSF_anti GATACAAAGCTTTCATTTCAGCGCCGCTTCGATT
TC (HindIII site underlined) 
orfB-A_pRSF_sense GATACAGATATCGATGACGCTAGACGAGCAGGT
CTGG (EcoRV site underlined) 
orfB-A_pRSF_anti GATACAGGTACCTCACACTGCCTCGATTTCGCCT
GG (KpnI site underlined) 
orfB-T_pRSF_sense GATACAGGATCCGATGCTGCCTTCGGTAATAAC
CGT (BamHI site underlined) 
orfB-T_pRSF_anti GATACAAAGCTTTCAATCAATGCGCGTGAAGTC






Table S3.2. List of plasmids and strains used in the kwf study. 
Insert Plasmid Host strain Source 
orfCDEFGHIJKBAT pETcoco-1 (Cam) E. coli BAP1 This study 
  








P. syringae pv. 
actinidiae NZV-13 
This study 
ΔB ΔE  
P. syringae pv. 
actinidiae NZV-13 
This study 
orfB A domain pRSF-duet (Kan) E. coli BL21 This study 
orfB T domain pRSF-duet (Kan) E. coli BL21 This study 
orfE1 A-T-C pRSF-duet (Kan) E. coli BL21 This study 
orfE2 A domain pRSF-duet (Kan) E. coli BL21 This study 
orfT domain pRSF-duet (Kan) E. coli BL21 This study 
orfA pLIC-His (Amp) E. coli BL21 This study 
orfB pLIC-MBP (Amp) E. coli Bap1 This study 
orfD pRSF-duet (Kan) E. coli BL21 This study 
orfE pLIC-MBP (Amp) E. coli Bap1 This study 
orfF pET30a (Kan) E. coli BL21 This study 
orfG pLIC-His (Amp) E. coli BL21 This study 
orfH pLIC-His (Amp) E. coli BL21 This study 
orfI pLIC-His (Amp) E. coli BL21 This study 
orfJ pLIC-His (Amp) E. coli BL21 This study 






Table S4.1. Primers used for cloning of individual pcm genes in E. coli. Nucleotides added 
for cloning are shown in bold. Restriction sites are underlined.  






(BamHI site underlined) 
Pcm2.1A_pRSF_anti GATACAAAGCTTTCAGACGACCACGGCGACCTC
TCG (HindIII site underlined) 
Pcm2.1T_pRSF_sense GATACAGGATCCGATGGTGCCCGCGGCGGTC 
(BamHI site underlined) 
Pcm2.1T_pRSF_anti GATACAAAGCTTTCACACGGGAGGGCGCGGCGA 
(HindIII site underlined) 
Pcm2.2A-MT_pRSF_sense GATACACATATGGTGGCGAATCCCGAGG (NdeI 
site underlined) 
Pcm2.2A-MT_pRSF_anti GATACAGATATCTCACTCGGTGTCGATCCGCTCG 
(EcoRV site underlined) 
Pcm2.2T_pRSF_sense GATACAGGATCCGATGGTCCCGACGGCCCTG 
(BamHI site underlined) 
Pcm2.2T_pRSF_anti GATACAAAGCTTTCAGTCACCCTTCTGACGGGC 






Table S4.2. List of plasmids and strains used in the pcm study. 
Insert Plasmid Host strain Source 
  A. bacterium OK006 127 
pcm2.2 pLIC-MBP (Kan) E. coli Bap1 This study 
pcm2.1 A pRSF-duet (Kan) E. coli BL21 This study 
pcm2.1 T pRSF-duet (Kan) E. coli BL21 This study 
pcm2.2 A-MT pRSF-duet (Kan) E. coli BL21 This study 
pcm2.2 T pRSF-duet (Kan) E. coli BL21 This study 
pcm11 pET30a (Kan) E. coli BL21 This study 




Table S4.3. 1H (600 MHz) NMR spectroscopic data for pepticinnamin E in MeOD. 
Protons are assigned based on chemical shift and peak splitting. Protons not observed in 
MeOD are labeled N/A. Protons that cannot be individually assigned based on 1H NMR 


















































Position Proton δH Multiplicity 
1 1-3H 0.89 t 
2 2-2H 1.42 h 





















































































15, 24, 36 
 
14, 23, 35, 
42, 43, 46 
 
5, 7, 8, 10, 
11, 17, 18, 









15-2H, 24-2H, 36-2H 
 
14-H, 23-H, 35-H, 42-
2H, 43-1H, 46-2H 
 
5-H, 7-2H, 8-2H, 10-H, 
11-H, 17-2H, 18-2H, 31-


























Figure S2.1. Plant immune response schematic. Diagram showing several MAMP-induced 
immune responses in a plant host cell. Upon elicitation by a MAMP, a plant cell may induce 
MAPK cascade activation, transcriptional reprogramming, calcium burst, ROS burst, synthesis 
of various secondary metabolites, and callose deposition. Collectively, these responses are 
sufficient to suppress pathogen proliferation. MAMP: microbe-associated molecular pattern, 
PRR: pathogen recognition receptor, TF: transcription factor, MEKK: mitogen-activated 
protein (MAP) kinase kinase kinase, MKK: MAP kinase kinase, MAPK: MAP kinase, CDPK: 






Figure S2.2. Pto_Δhsv mutants do not display significantly reduced virulence on A. 
thaliana. Bacteria were counted after recovery from Pto-wildtype and Pto_Δhsv mutants on A. 
thaliana seedlings. The experiment was repeated twice with similar results. The mutants in 
both experiments displayed slightly reduced growth but this was not statistically significant 




Figure S2.3. The hsv operon suppresses callose deposition in A. thaliana induced by 
components encoded by the T3SS locus. Leaves of 4-week-old A. thaliana were infiltrated 
with the P. fluorescens strains noted at bottom and stained with aniline blue, ~20 h post 
infiltration. **, p-value ≤ 0.01; t-test. Error bars represent standard errors. This experiment was 




Figure S2.4. Identification of phevamines by comparative metabolomics. The LC-MS 
metabolic profiles are compared between the extract of E. coli overexpressing hsv and E. coli 
control containing the empty vector.  The fold change (log2) for each metabolite is plotted 
against the p-value (log10) for that metabolite. Data points for pre-phevamine (pPHV), 
phevamine A (PHVA), and phevamine B (PHVB) are highlighted in red. The average fold 
change is very large for pre-phevamine (430 fold increase), phevamine A (1600 fold increase), 
and phevamine B (540 fold increase) comparing hsv overexpression and the empty vector 
control. When the fold change for a metabolite is large, the level in each sample tends to vary 
more. The relatively large p-values for these metabolites may be due to variable protein levels 






Figure S2.5. Production of pre-phevamine by different bacterial strains. Extracted ion 
chromatograms are shown for pre-phevamine (m/z, 287.255) detected in the extracts of each 
bacterial strain. The retention time of pre-phevamine is approximately 3.8 minutes. Pre-
phevamine is not produced by Pto∆hsv (hsv deletion mutant in Pto) (gray). Pre-phevamine is 
produced by Pto∆hrpL (hrpL deletion mutant in Pto) (orange), wildtype Pto (black), Pto 
pBAD:hrpL overexpression (red), and E. coli overexpressing the hsv operon (blue). Pre-
phevamine is also produced in the in vitro enzymatic reaction and was purified by HPLC 
(brown). The in vitro purified standard was co-injected with the hrpL overexpression extract 
(pink) and the wildtype Pto extract (green), both showing a single peak for pre-phevamine. In 
(D), (E), and (G), the additional pre-phevamine peaks result from in-source fragmentation of 
phevamine A or phevamine B as labeled. Lowering the fragmentor voltage reduced these in-
source fragmentation peaks. Two metabolites from extractions, 1 and 2, are structurally 




Figure S2.6. Production of phevamine B by different bacterial strains. Extracted ion 
chromatograms are shown for phevamine B (m/z, 581.392). Phevamine B is not produced by 
Pto∆hsv (hsv deletion mutant in Pto) (orange), Pto∆hrpL (hrpL deletion mutant in Pto) (green), 
wildtype Pto (brown), or Pto pBAD:hrpL overexpression (pink). Phevamine B is only detected 





Figure S2.7. Phevamine A production in P. fluorescens Pf0-1 is independent of T3SS. 
Extracted ion chromatograms of phevamine A (m/z 434.324) are shown. Phevamine A is 
detected in both Pf0-1 strains expressing hsv, Pf0-1+T3SS+hsv (green) and Pf0-1+hsv (red), 
indicating that the T3SS is not required for the secretion of phevamine A. Phevamine A is not 






Figure S2.8. Structural analyses of pre-phevamine and phevamines by tandem mass 
spectrometry (LC-MS/MS). (A) MS/MS spectrum of pre-phevamine (m/z 287.255). (B) 





Figure S2.9. Identification of the regioisomers of phevamine A by LC-MS/MS. A 100 m/z 
fragment is unique to the amidinotransfer product on the propylamine end of spermidine 
(regioisomer A), and a 114 m/z fragment is unique to the amidinotransfer product on the 
butylamine end of spermidine (regioisomer B). Both isomers are detected from the in vitro 
reaction and E. coli overexpression. In culture extracts of wildtype Pto, only regioisomer A 




Figure S2.10. Production of phevamines and detection of pathway intermediates by 
sequential in vitro enzymatic assays. Extracted ion chromatograms are shown for (A) 
amidinospermidine (m/z 188.187) from HsvA reaction, (B) pre-phevamine (m/z 287.255) from 
HsvA reaction followed by HsvC reaction, and (C) phevamine A (m/z 434.324, green) and 
phevamine B (m/z 581.392, blue) from sequential reactions of HsvA, HsvC, and HsvB. In (B), 
the second small peak for pre-phevamine comes from in-source fragmentation of Compound 
3, the mass of which corresponds to Val-Val-Val-amidinospermidine, an in vitro byproduct of 
the HsvC reaction. In (C), the second peak for phevamine A is the result of in-source 




Figure S2.11. In vitro reconstitution of HsvA activity. HsvA was incubated with spermine, 
spermidine, and L-lysine as the acceptor of the amidino group and L-arginine as the donor of 
the amidino group. Extracted ion chromatograms are shown for amidinospermidine (m/z 
188.187), amidinospermine (m/z 245.245), and homoarginine (m/z 189.135), which are the 






Figure S2.12. HsvB activates L-Phe as the preferred substrate. Several pairs of amino acids 
were incubated with HsvB and the released inorganic phosphate (Pi) was measured using the 
PiColorLock assay described in the Methods. The amino acid pairs are (A) L-Ser and L-Orn, 
(B) L-Ala and L-Lys, (C) L-Ala and L-Phe, (D) L-Arg and L-Trp, and (E) 2x L-Phe. The assays 
containing L-Phe ((C) and (E)) produced the most Pi, indicating that L-Phe is the preferred 






Figure S2.13. Production of phevamine A and B depends on HsvB concentration. 
Reaction mixtures containing 100 µM pPHV, 20 µM Phe, and varying amounts of HsvB were 
incubated at room temperature for 2 hours. As the concentration of HsvB increased, the amount 
of phevamine B (m/z 581.392) increased (pink, red, and blue). The ratio of phevamine A (m/z 
434.324) (orange, black and green) to phevamine B is the highest at low concentration of HsvB. 
The peak around 11 minute retention time in phevamine A traces is a result of in-source 









Figure S2.14. 1H NMR (600 MHz) of in vitro synthesized and purified phevamine A. 




Figure S2.15. (1H,1H)-dqfCOSY spectrum (800 MHz) of in vitro synthesized and purified 




Figure S2.16. (1H,13C)-HMBC spectrum (800 MHz) of in vitro synthesized and purified 




Figure S2.17. (1H,13C)-coupled-HSQC spectrum (800 MHz) of in vitro synthesized and 






Figure S2.18. 1H NMR (600 MHz) of in vitro synthesized and purified phevamine B. 




Figure S2.19. (1H,1H)-dqfCOSY spectrum (800 MHz) of in vitro synthesized and purified 




Figure S2.20. (1H,13C)-HMBC spectrum (800 MHz) of in vitro synthesized and purified 




Figure S2.21. (1H,13C)-coupled-HSQC spectrum (800 MHz) of in vitro synthesized and 





Figure S2.22. 1H NMR (400 MHz) of the phevamine A synthetic standard (9). Spectrum 





Figure S2.23. Iron binding activity of phevamine A. The ability of phevamine A to bind 
iron was tested and compared to EDTA standards using a chromeazurol S (CAS) assay. Upon 
binding of ferric iron, the chromeazurol S dye changes color from blue to yellow. No color 
change was observed for phevamine A at a concentration of up to 10 mM, thus it is unlikely 





Figure S2.24. Polyamines enhance the flg22-induced ROS burst in N. benthamiana. (A) 























































































10 nM of flg22 with or without polyamines at 400 µM. Put: putrescine, Spd: spermidine, and 
Spn: spermine. (B) Dose-dependent effect of spermidine on the flg22-induced ROS burst. Leaf 
disks were challenged with 10 of nM flg22 and various concentrations of spermidine. (C) The 
increase of the flg22-induced ROS burst by spermidine is not due to an additive effect. Leaf 
disks were treated with distilled water (DW), 10 nM of flg22, 10 nM of flg22 with 400 µM of 
spermidine, or 400 µM of spermidine only. Experiments presented in panels (A) and (C) were 
performed more than 3 times with similar results. The experiment presented in panel (B) was 




Figure S2.25. Effect of spermidine on early MTI responses in A. thaliana. (A) Spermidine 
potentiates the flg22-induced ROS burst. Leaf disks were treated with distilled water (DW), 
flg22 at 10 nM, flg22 with spermidine at 300 µM or spermidine only at 300 µM. ROS levels 
were measured. This assay was repeated more than 3 times with similar results. (B) 
Potentiation of the flg22 ROS burst by spermidine is dependent on FLS2. Leaf disks from Col-
0 or the fls2 mutant were challenged with flg22 only at 20 nM or with spermidine at 300 µM. 
This experiment was performed twice with similar results. (C) Spermidine potentiates the 
elf18-induced ROS burst. Leaf disks were challenged with DW, elf18 at 50 nM, elf18 
supplemented with spermidine at 400 µM, or with spermidine only at 400 µM. This experiment 
was performed twice. (D) Spermidine suppresses the flg22-induced calcium burst. Col-
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0_pMAQ2 leaf disks were treated with DW, flg22 at 25 nM, flg22 at 25 nM with spermidine 
at 400 µM, or with spermidine only. This experiment was repeated more than 3 times. Error 





Figure S2.26. Arginine potentiates the flg22-induced ROS burst in N. benthamiana. (A) 























































































at 10 nM, arginine and citrulline were used at 400 µM. This experiment was performed twice 
with similar results. (B) Dose-dependent effect of arginine on the flg22-induced ROS burst. 
flg22 was used at 100 nM and arginine at various concentrations. This experiment was 
performed twice with similar results.  (C) The increase of the flg22-induced ROS burst by 
arginine is not due to an additive effect. flg22 was used at 10 nM and arginine at 400 µM. This 





Figure S2.27. Phevamine A, but not pre-phevamine, suppresses the arginine potentiation 
of the flg22-induced ROS burst in both N. benthamiana and A. thaliana. (A) Phevamine 
A, but not pre-phevamine, suppresses the arginine ROS potentiation in N. benthamiana. flg22 
was used at 5 nM; arginine, pre-phevamine and phevamine A at 300 µM. (B) Phevamine A, 
but not pre-phevamine, suppresses the arginine ROS potentiation in A. thaliana. flg22 was 
used at 5 nM; arginine, pre-phevamine, and phevamine A at 300 µM. PHVA: Phevamine A, 




























































Figure S2.28. Arginine and polyamine biosynthetic pathways are targeted by pathogens 
via different mechanisms. Spermidine and L-arginine potentiate the flg22-induced ROS burst. 
The role of nitric oxide production in this potentiation remains uncertain.128 Phevamine A 
suppresses the spermidine/L-arginine potentiation of the flg22-induced ROS burst. 
Phaseolotoxin inhibits the synthesis of arginine and polyamines pathway by suppressing the 
activity of ODC and OCT, while phevamine A targets the potentiation mediated by spermidine 
and L-arginine. The effector AvrBsT from Xanthomonas campestris pv. vesicatoria (Xcv) 
interacts (red double arrow) with ADC1 in pepper.129 ODC: ornithine decarboxylase, OCT: 
ornithine carbamoyltransferase, ADC: arginine decarboxylase, SPDS: spermidine synthase, 
SPMS: spermine synthase, ROS: reactive oxygen species, NO: nitric oxide, PHVA: phevamine 





Figure S2.29. Strategy to generate P. syringae clean deletion mutants. A fusion of the 5’ 
and 3’ flanking region of the hsv operon was generated by chimeric PCR and cloned into 
MTN1907. After transformation of the parental strains (Pto, Pto-Cor -, PtoD28E), the first 
recombination integrates the plasmid either at the 5 ’or 3’ end of the hsv operon. Merodiploids 
are selected on media containing tetracycline and genotyped by PCR. The second 
recombination event either leads to a reversion to the original locus or the generation of the 
 
147 
clean mutant. Recombined strains were selected on plates containing sucrose (5%) and clean 




Figure S2.30. Genotyping of the clean deletion mutants and the complemented strain.  (A) 
Graphical representation of the plasmids used for molecular manipulation of P. syringae. The 
left panel represents the MTN1907 plasmid used to engineer the mutants. The right panel 
represents the pBAV226 plasmid in which the hsv operon was cloned downstream of the NptII 
promoter for complementation of PtoD28E_∆hsv2. Tet: confers resistance to tetracycline; 
mobA, mobB, mobC: RSF1010 mobilization genes; ori: high-copy-number origin of 
replication; SacB: a secreted levansucrase that renders bacteria sensitive to sucrose for counter-
selection; KanR_inactive: aminoglycoside phosphotransferase gene inactive in P. syringae; 
pVS1 StaA: the stability protein from the Pseudomonas plasmid pVS1; pVS1 RepA: a 
replication protein; p15A ori: p15A origin of replication for propagation in E. coli cells; pVS1 
oriV: origin of replication of the pVS1 plasmid; Gm: the gentamycin acetyltransferase. (B) 
Graphical representation of the hsv locus in the wildtype parental strains (Pto-WT, Pto-Cor -, 
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PtoD28E), and the clean deletion mutants. Arrows represent the primers used for the 
genotyping. OS: operon specific primer, G: genomic primer, KO: knockout primer, +: forward 
primer, -: reverse primer (see Supplementary Table S2.2 for primer sequences). (C) Analytical 
PCRs performed to confirm the genotype of the mutants generated in this study. PCR programs 
include a 1 min extension time, designed for amplification in mutant strains, but too short for 

































Figure S2.32. 1H NMR (400 MHz) of Fmoc-(S)-Val-bis-Boc-spermidine (5). Spectrum 














Figure S2.33. 1H NMR (400 MHz) of Fmoc-(S)-Phe-(S)-Val-bis-Boc-spermidine (6). 














Figure S2.34. 1H NMR (400 MHz) of Fmoc-(S)-Phe-(S)-Val-spermidine (7). Spectrum 














Figure S2.35. 1H NMR (600 MHz) of Fmoc-(S)-Phe-(S)-Val-spermidine-N,N’-di-Boc-1H-







Figure S3.1. Agar diffusion assays for KB-1. Varying concentrations of KB-1 were plated 
on filter paper atop M9 agar media plated with (A) P. syringae Cit7, (B) E. coli MG1655, (C) 
P. fluorescens Pf0-1, (D) P. putida S12, and (E) P. aeruginosa PA14. No zones of inhibition 
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